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Dry eye is a complex, multi-factorial disease that results in a compromised tear film and 
ocular surface. Clinicians and researchers alike have historically relied on an individual’s symptoms 
to diagnose and manage the condition, due to a lack of reliable objective methods for quantifying 
disease presence and severity. Of late, parameters such as tear film osmolarity and tear meniscus 
height have shown promise as valid methods for enumerating characteristics of the tear film that may 
aid the diagnosis of dry eye. 
Two new technologies have recently been introduced that can measure said parameters. The 
TearLab™ is a novel handheld nano-osmometer capable of measuring tear film osmolarity on 
samples as small as 50 nL. The device uses electrical conductance to measure osmolarity, and the 
small sample requirements purportedly allows the device to minimally disturb the natural state of the 
tear film. The RTVue-100 is a spectral-, or Fourier-domain optical coherence tomographer that has 
the ability to generate high resolution, cross-sectional images of the tear meniscus, and subsequently 
measure tear meniscus height. As little is published on the use of these technologies to evaluate the 




Aim: To compare anterior segment spectral-domain OCT (SOCT) tear meniscus height measures to 
those from the more commonly used time-domain OCT (TOCT). 
Methods: The right eye of 50 healthy subjects had images of their TMH captured with TOCT (OCT2, 
Carl Zeiss Meditec, Dublin, CA, USA) and SOCT (RTVue-100, Optovue, Freemont, CA, USA). Data 
were acquired using two different anterior segment lenses, the CAM-S and CAM-L on the SOCT. 
Images were then analyzed for differences in their derived TMH.     
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Results: The average TMH for TOCT was 0.280 ± 0.139mm, while the mean TMH measured using 
the SOCT was 0.354 ± 0.163mm and 0.345 ± 0.167mm for the CAM-S and CAM-L respectively. 
There was a significant difference (p < 0.001) when comparing TOCT to either of the SOCT lenses. 
There was no statistically significant difference between the CAM-L and CAM-S (p=1.0). Bland-
Altman analysis showed poor agreement between TOCT and SOCT (95% limits of agreement -0.138 
to +0.285mm for the CAM-S and -0.185 to +0.315mm for the CAM-L). 
Conclusion: The RTVue-100 produces TMH measurements that are significantly higher than OCT2 
in a normal patient population. However, the RTVue-100 showed a number of other advantages over 
the OCT2 in the measurement and analysis of images. Future work needs to determine the causative 
factors behind the observed differences. 
Chapter 3: 
Aim: To generate data on the performance of the TearLab™ nano-osmometer in a control and dry eye 
population. Of particular interest is which time interval between successive tear collections, 15 
minutes or 1 minute, yields the most repeatable result in normals and those with dry eye. A secondary 
outcome is the determination of the effect, if any, that tear collection using glass capillary tubes has 
on osmolarity of the sample. 
Methods: This was a two-phase study that recruited 20 subjects (10 normals / 10 dry eye) for 
participation in phase I and 30 subjects (15 normals / 15 dry eye) for participation in phase II. As part 
of phase I, subjects had eight tear collections performed on each eye at each of three visits, four 
separated by 15 minutes and four separated by 1 minute. Phase II consisted of four visits, each visit 
involving the collection of four tear samples using the TearLab™, and one collection of 5 µL using a 




Results: During phase I, mean osmolarity in the control group was 287.9 ± 7.5 mOsm/L and for the 
dry eye group, mean osmolarity was 297.8 ± 14.7 mOsm/L, a difference that was statistically 
significant (p=0.007). Significant differences were also observed between groups for OSDI (p<0.001) 
and TBUT (p=0.029). No significant difference was observed whether collections were performed at 
15 minutes or 1 minute, and intraclass correlation coefficients were 0.899 and 0.923, respectively. A 
bilinear function fit to osmolarity and TBUT data showed a strong relationship between the two 
variables. During phase II, mean osmolarity was 287.7 ± 8.01 mOsm/L in the control group and 295.8 
± 12.5 mOsm/L in the dry eye group (p = 0.0058). When using the glass capillary tube, mean 
osmolarity dropped to 282.4 ± 9.8 mOsm/L in the control group and 291.1 ± 9.9 mOsm/L in the dry 
eye group. Comparisons between measures taken directly with the TearLab™ and those with the 
capillary tube were significantly different in the control group (p = 0.006), but were not significantly 
different in the dry eye group (p = 0.10). 
Conclusion: No change in osmolarity was observed whether tears were collected in rapid succession 
or given time to equilibrate. To improve collection efficiency, a 60-90 second time interval between 
consecutive tear collections using the TearLab™ is advocated to avoid perturbation of the tear film’s 
natural state. Tear collection using a glass capillary tube appears to induce a reflex tearing response, 
which results in an artificial lowering of tear osmolarity. The relationship observed between tear 
osmolarity and TBUT suggests that those suffering from dry eye have an inherent tear film instability. 
Chapter 4: 
Aim: To use in vitro methods to determine the effect of different TearLab™ chip card production lots 
on osmolarity, and the effect of glass capillary tube collection on osmolarity. 
Methods: Three different chip card lots (Code 3, 5 and 10) were used to measure osmolarity of two 
control solutions with known osmotic concentration: 292 mOsm/L and 338 mOsm/L. Six measures 
were taken on each control solution with each chip card lot. The same two control solutions, in 
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addition to a contrived artificial tear solution with an osmolarity of 294 mOsm/L, were also measured 
directly with the TearLab™ or glass capillary tube. 18 measures were obtained on each solution using 
each method, for a total of 108 measures. 
Results: Regardless of control osmolarity, batch 10 was significantly different than batch 3 or 5 (p < 
0.002), while the mean osmolarity of batch 3 and 5 were statistically similar (p > 0.78). Mean 
osmolarity of those samples taken directly from the vial was 295.8 ± 19.22 mOsm/L, and 300.3 ± 
18.9 mOsm/L for those that were first collected via capillary tube, a difference which was not 
statistically significant (p = 0.23). 
Conclusion: Different TearLab™ chip card production lots can have an effect on the measured tear 
osmolarity, and therefore caution must be used when comparing measures over time. In vitro use of 
the glass capillary tube to collect fluid samples does not significantly influence osmolarity values. 
Chapter 5: 
Aim: To determine if any relationship exists between tear osmolarity measures and tear meniscus 
height, and whether symptoms of dry eye correlate with either variable. 
Methods: 45 subjects completed linear visual analogue scales (VAS) that graded five symptoms of 
dry eye (comfort, dryness, burning, grittiness and clarity of their vision). This was followed by three 
measures of the lower tear meniscus height using the RTVue-100, and four measures of tear 
osmolarity using the TearLab™, both procedures being performed on each eye. Subjects were 
grouped into one of four categories based on a combination of their mean osmolarity and TMH, using 
300 mOsm/L and 0.3mm as a cut-off respectively. 
Results: Mean TMH for the right eye was 0.281 ± 0.123mm and for the left eye was 0.297 ± 
0.130mm, a difference that was not statistically significant (p = 0.34). Osmolarity values for the right 
and left eye, 302.9 ± 16.4 mOsm/L and 301.2 ± 14.8 mOsm/L respectively, were also not 
significantly different (p = 0.21) and Pearson’s correlation coefficient failed to establish a significant 
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relationship between TMH and osmolarity (r = -0.14, p = 0.36). No difference was observed between 
each of the five symptoms rated as part of the linear VAS (p = 0.99), and no relationship between any 
of the symptoms and signs could be established regardless of which group was evaluated. 
Conclusion: There does not appear to be a relationship between osmolarity and TMH, and no 
predominant symptoms could be identified within distinct dry eye groups. Nonetheless, the present 
study has made some interesting observations regarding the possible development of dry eye and its 
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1.1 The normal tear film 
Historically, the tear film has been thought of as a trilaminar fluid, with an outermost lipid 
layer, a thick central aqueous layer, and a pre-epithelial mucus layer.1 In recent years this model has 
evolved, and the tear film is now described as an aqueous gel gradient with an overlying lipid layer.2 
This inner aqueous layer consists of a dense mucin-phase closest to the ocular surface, and a 
decreasing density of mucins as one moves toward the lipid layer. Each component of the tear film 
has a distinct origin and purpose.  
The aqueous portion is primarily produced by the lacrimal and accessory lacrimal glands, 
namely the glands of Wolfring and Krause. There are numerous constituents that make up this layer, 
including water, oxygen, proteins, electrolytes, growth factors, peptides and inflammatory mediators. 
The predominant electrolytes in the tear film are sodium, potassium, magnesium, calcium, chloride, 
and bicarbonate, and phosphate ions are found within the tear film aqueous layer. These electrolytes 
serve to maintain the pH of the tear film (normally 7.2 – 7.6)3 and also play a role in determining its 
osmolarity.4 The major proteins of the aqueous play an integral role in defence of the ocular surface. 
Among these proteins are lysozyme (an enzyme that attacks the peptidoglycan cell walls of gram-
negative bacteria and buffers the tear film),5 lipocalin (a lipid scavenging protein that plays a role in 
forming the surface tension of the tears and has also been shown to have endonuclease function),6, 7 
lactoferrin (which has anti-microbial activity via its ability to sequester iron ions, in addition to anti-
inflammatory effects, and promotes cell growth and DNA synthesis)8 and secretory IgA (an antibody 
that plays a role in mucosal immunity).9 These four proteins each count for 15-20% of the total 
protein contained within the tear film.10 
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Approximately 20 ocular mucins have been identified and they can be divided into two 
classes: secreted and soluble.11 The secreted ones are typically membrane-bound to the cells that 
produce them, the corneal and conjunctival epithelia. They form the glycocalyx, which is a gelatinous 
layer of secreted mucins that provides a lubricating layer, and ensures an even spread of the tear film 
over the hydrophobic epithelial cells.12 Other research has shown the glycocalyx to have an 
antimicrobial effect, as it prevents adherence of bacteria, viruses and inflammatory cells to the ocular 
surface.13 The soluble mucins, most notably MUC 5AC secreted by the conjunctival goblet cells, 
interact with the membrane-bound mucins and the aqueous layer to form a gel that traps water.14 This 
ensures that the mucin gel remains hydrated and can function to protect and maintain the epithelium 
from environmental insults. 
The lipid layer is secreted by the meibomian glands and functions to eliminate evaporation of 
the aqueous layer and facilitate the tear film spreading over the corneal surface. Lipids are only found 
on the anterior surface of the tear film, and this is thought to be because any free lipids circulating in 
the aqueous are immediately bound to lipocalin.15 The meibomian lipid is made up of phospholipids, 
free fatty acids and cholesterol.16 
The lacrimal glands, meibomian glands and goblet cells are collectively integrated into a 
system known as the Lacrimal Functional Unit (LFU). The LFU also includes the cornea, 
conjunctiva, and sensory and motor nerves of the ocular surface, and is chiefly responsible for the 
health of the ocular surface via the production of tears.17 Basal tear production is primarily controlled 
by constant stimulation of the trigeminal sensory fibres, which passes through to the pterygo-palatine 
ganglion to post-ganglionic fibres that terminate in the lacrimal and meibomian glands and goblet 
cells.17 Reflex tears are a response to external physical or chemical stimuli of the trigeminal nerve, 
and follow the same afferent and efferent pathway as basal tears.18 A third type of tears, emotional, 
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are generated in higher centres of the brain and may be a response to a variety of emotions, including 
fear, sadness, and anger, among others.19 
1.2 Purpose of the tear film 
The tear film has three primary functions: creation of a high quality refracting interface, 
maintenance of epithelial cell health, and protection of the ocular surface.  The tear film-cornea 
combination has been shown to provide the eye with 80% of the eye’s refractive power.20 Therefore, a 
smooth, even tear film provides optimal vision, and any deviations in tear film stability will result in 
increased aberrations and decreased visual acuity.21 In addition to a smooth refracting surface, a 
requirement of ideal vision is a cornea that is transparent. It achieves this is by being a virtually 
avascular tissue, which creates a problem for the corneal epithelial cells to receive the necessary 
nutrients to continue to function. This issue is overcome by the tear film, which constantly bathes the 
ocular surface and creates the required trophic environment. Limbal vessels are too far away to 
supply the oxygen demands of the entire cornea, so the tear film is called upon to act as an 
intermediary between the oxygenated air and the corneal epithelium. It also contains approximately 
25µg/mL of glucose,22 providing a secondary source of glucose in addition to that supplied by the 
aqueous humor. Finally, it contains a number of growth factors, anti-oxidants and peptides that 
encourage wound healing and corneal regeneration.10 One of the most important purposes the tear 
film serves is to protect the ocular surface from insult, both physical and antimicrobial. It provides 
physical protection by washing away harmful contaminants such as allergens, bacteria, or airborne 
pollutants through the process of reflex tearing, in conjunction with the blink reaction. The mucous 
layer serves as a physical barrier to prevent bacteria from accessing the corneal epithelium by 
trapping, adsorbing and removing them from the ocular surface.23 It also acts as a lubricant to reduce 
the shear forces exerted on the eye during each blink.11 Antimicrobial protection is provided via two 
mechanisms, one being the active enzymes lysozyme and lactoferrin (among others) outlined 
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previously, and the other is a complex, immunologically-derived response from lymphocytes and 
cytokines such as IL-1, TNF and TGF-β.23 
A breakdown in function of any of the layers or constituents of the tear film can result in 
destabilization, which over time may affect the ocular surface and ultimately result in what is known 
as dry eye. 
1.3 What is dry eye? 
 In 2006, the Dry Eye Workshop (DEWS) convened a sub-committee of leading experts on 
dry eye with the stated goal of redefining the term dry eye.24 Using the definition that came out of the 
1995 National Eye Institute/Industry Dry Eye Workshop as a framework,25 the sub-committee 
integrated new knowledge regarding the core mechanisms and visual consequences of dry eye to 
come up with the following definition: 
‘Dry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of 
discomfort, visual disturbance, and tear film instability with potential damage to the ocular 
surface. It is accompanied by increased osmolarity of the tear film and inflammation of the 
ocular surface.’24 
As shown in Figure 1-1, a complex cycle is behind the development of dry eye, and it was the opinion 
of the committee that the core mechanisms are tear hyperosmolarity and tear film instability. Tear 
hyperosmolarity activates a cascade of signalling molecules within the surface epithelial cells, which 
leads to the release of inflammatory mediators at the ocular surface.26-28 Epithelial injury causes 
epithelial damage, a loss of goblet cells, and a disturbance of mucin expression leading to tear film 
instability.29-30 This instability leads to tear-break up and hyperosmolarity, creating a vicious circle of 
events. The aetiology of dry eye is generally broken down into two classes: aqueous-deficient dry eye 
(ADDE) and evaporative dry eye (EDE). It is important to note that these two classes are not 





Figure 1-1. Mechanism of dry eye as hypothesized by the sub-committee on the definition of dry 
eye as part of the Dry Eye Workshop (reproduced with permission from Ocular Surface 2007. 5(2):75-92). 
ADDE is primarily attributed to reduced secretion of the aqueous layer due to lacrimal 
dysfunction, most commonly the result of an inflammatory reaction.31 ADDE can be loosely sub-
divided into two categories: Sjögren Syndrome dry eye and non- Sjögren Syndrome dry eye. Sjögren 
syndrome dry eye is a devastating chronic autoimmune disorder of the exocrine glands with 
associated lymphocytic infiltration of the lacrimal gland that impairs its proper functioning.32 Non- 
Sjögren syndrome dry eye is usually the result of lacrimal deficiency, or lacrimal duct blockage, 
although systemic medications have been shown to be a factor.33 In ADDE, it is hypothesized that the 
tear film becomes hyperosmolar due to the low volume of tears present on the ocular surface, in 
combination with a normal to increased rate of evaporation.34 EDE is a result of increased evaporation 
of the tears from the ocular surface in the presence of a normally-functioning lacrimal gland, 
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ultimately increasing the osmolarity of the tear film.24 Its causes have been sub-divided into intrinsic 
(causes which are the result of lid dysfunction, most commonly meibomian gland dysfunction) or 
extrinsic (external causes, including contact lens wear and allergy). The effects of EDE may not be as 
apparent in the initial stages of the disease, as a reflex compensatory response of the lacrimal gland 
can help in maintaining a normal osmolarity. However, excessive reflex stimulation of the lacrimal 
gland can induce an inflammatory response within the gland, leading to the release of inflammatory 
mediators into the tears and exacerbating the symptoms of dry eye.35 
 The prevalence of dry eye in the United States varies widely, and has been reported to be 
between 7.8%36 and 14.6%37 in large population-based studies. Incidence of dry eye has been 
evaluated using data from the Beaver Dam study, and was reported as 21.6% over a 10-year period.38 
In Europe, prevalence has been estimated to be <0.1%,39 while in Japan, Shimura used questionnaires 
to determine a prevalence of 33%.40 Closer to home, the CANDEES (Canadian Dry Eye 
Epidemiology Study) study noted a prevalence of approximately 1 in 4 among patients presenting for 
routine optometric care.41 The reason for the variation in prevalence and incidence estimates depends 
on countless factors, including the population characteristics, definition of dry eye used to make the 
diagnosis, and perhaps most importantly, the tests used to make the diagnosis. Many large-scale 
epidemiological studies use questionnaires in lieu of objective tests, which can be an issue due to the 
poor correlation between signs and symptoms, and also because of the tendency of those who are ill 
to respond to questionnaires, over-representing the condition.41-43 
 The social and economic impact of dry eye cannot be overstated. Those suffering from dry 
eye are significantly more likely than those without dry eye to report problems reading, performing 
professional work, and driving during the day or night.44 Schiffman et al. did a utility assessment 
evaluated by the time-trade off method and found that those with moderate-to-severe dry eye had 
similar utility scores to moderate angina, highlighting how significantly dry eye impacts an 
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individual’s life.45 The economic impact is difficult to assess, as the costs may be direct (office visits, 
medication), indirect (lost workplace productivity, sick days) and intangible (decreased quality of 
life).46 One study estimated that monthly out of pocket costs are $25 in a non-Sjögren Syndrome dry 
eye population.47 The same study showed that dry eye interfered with work an average of 184 days 
per year, which the authors estimated to be a productivity loss of >$5000 per patient per year.47 Older 
estimates have placed the cost of artificial tears for the relief/treatment of dry eye within the US to be 
$100 million dollars,48 an estimate that is likely much higher now considering the significant increase 
in the population over age 65 in North America.49-50  
 A secondary goal of the DEWS report was to come up with a globally agreed upon criterion 
for the screening, diagnosis and monitoring of dry eye .51 The aim was to use single tests or a 
combination of tests that could be performed in a clinical environment in a cost-effective manner, 
with appropriate sensitivity and specificity. It was also imperative that accepted cut-offs be derived 
for tests to aid in the appropriate discrimination of those affected and unaffected with the disease. 
They ultimately agreed that some of the most important existing and emerging technologies for the 
screening and diagnosis of dry eye included: symptom assessment through the use of questionnaires, 
the assessment of tear stability using tear break-up times, the measurement of tear osmolarity, and the 
measurement of tear meniscus height as an estimate of tear volume.51 
1.4 Questionnaires 
 Many would argue that dry eye is a symptom-driven disease, and questionnaires are a simple 
and effective means of screening individuals for its presence. Some of the most commonly used 
validated questionnaires include the McMonnies dry eye history questionnaire,52-54 the Ocular Surface 
Disease Index (OSDI),55-56 and the Dry Eye Questionnaire (DEQ).57-58 Common features among the 
four questionnaires include an evaluation of the frequency and intensity of symptoms, effect of 
symptoms on daily function and vision, and the effect of environment, among others.43 Linear visual 
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analogue scales have also been employed with success, although this is not a validated method of 
symptom evaluation.59 
 McMonnies was one of the first to develop a comprehensive dry eye questionnaire based on 
an evaluation of available literature at the time.52 The result was a 14-item questionnaire primarily 
consisting of questions with yes/no answers, and some questions dedicated to the elucidation of 
various risk factors, including contact-lens wear, medications, gender and age. An evaluation of 
symptoms (soreness, scratchiness, dryness, grittiness, burning) was also included. A scoring index for 
the questionnaire allows possible scores to be between 0 and 45, a higher score presumed to correlate 
with increased severity. The sensitivity and specificity of the questionnaire for the diagnosis of dry 
eye when a cut-off of >14.5 is used has been reported to be as high as 98% and 97% respectively;54, 60 
however, a psychometric validation study of the questionnaire determined that using a cut-off score of 
>14.5 yielded a sensitivity of 82% and specificity of 36%.61 The questionnaire also demonstrates poor 
internal reliability, suggesting its use as an indicator of treatment success may be limited.61 
 The OSDI is a twelve item questionnaire that uses a Likert scale to evaluate the frequency of 
symptoms over a 1 week period.55 Factor analysis revealed that there are 3 sub-scales within the 
OSDI: vision-related function (6 questions), ocular symptoms (3 questions) and environmental 
triggers (3 questions).56 Possible scores of the OSDI range between 0 and 100, and as with the 
McMonnies questionnaire, a greater score represents greater disability. A cut-off of 17 has been 
suggested to maximize sensitivity and specificity of the test at differentiating between normals and 
those with severe dry eye, although scoring is usually broken down into 0-12 (normal), 13-22 (mild), 
23-32 (moderate) and >33 (severe).56 Internal reliability and test-retest repeatability of the OSDI is 
markedly higher than the McMonnies,56 making it a popular test for use in clinical trials.62-66 
However, to use the OSDI to chart treatment efficiency, it is important to know the minimal clinically 
important difference (MCID), which is the smallest difference in test score that would mandate a 
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change in a patient’s management. Miller determined that the MCID for mild-moderate dry eye is 4.5 
– 7.3, and the MCID for severe disease is 7.3 – 13.4.67 This can be interpreted as meaning that an 
improvement in a mild-moderate subject’s OSDI score of 4.5 represents a true improvement in 
symptoms. 
 The DEQ is a 21-item questionnaire developed by Begley et al. that evaluates risk factors in 
addition to the frequency of specific symptoms.57 A five-question subset of this questionnaire was 
recently validated, the five questions pertaining to the frequency with which eye discomfort, dryness 
and watering occurred, and the end-of-day severity of the discomfort and dryness.68 It was found that 
this simple five item questionnaire could discriminate between those with and without dry eye, with a 
sensitivity of 90% and specificity of 81% using a score of ≥6.68 Work has been done comparing the 
above three questionnaires to one another using Spearmann correlations, which found significant 
correlations between the overall scores.69 The authors suggested that the three questionnaires are 
measuring the same thing (ocular dryness symptoms) based on their unidimensionality, and therefore 
advocated using only one of the questionnaires at a given time.69 
 Despite being a non-validated measure, linear analogue scales have demonstrated utility in 
giving additional insight into the severity of various symptoms of dry eye. These are simple scales 
from 0 – 100, with 100 representing the absence of the symptom, and 0 representing a severe 
manifestation of the symptom. The primary disadvantage of these scales is their non-linearity and 
large response range, which can make analysis and interpretation of the results difficult.70 
1.5 Tear stability 
 A stable tear film is a necessary component of a healthy ocular surface, and a requirement for 
clear vision.21, 71-72 As mentioned earlier, deviations in the constituents and composition of the tear 
film can lead to instability, jeopardizing vision and the comfort and health of the ocular surface. Its 
recognition in the DEWS report as a core mechanism in dry eye has made the dynamics of tear film 
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instability an area of great interest; however, the physical phenomenon itself is still poorly 
understood. Mechanisms that have been proposed include contamination of the aqueous mucins by 
the inward movement of lipids,73 malformation of the glycocalyx,74-75 and the contamination of the 
tear film by external debris,76 in addition to molecular causes such as the influence of Van der Waals 
attractions.77 
 Norn proposed the measure of corneal wetting as a clinical method to evaluate tear stability, 
which he defined as the interval between the last blink and the appearance of a break in the tear film 
when observed under a cobalt blue filter using fluorescein.78 This measure was later termed tear 
break-up time (TBUT), and arguably remains the most commonly performed evaluation of the tear 
film in both clinical and research settings.79 Despite its popularity, a primary issue with the 
measurement of TBUT is the use of fluorescein and its possible effects on the outcome of the test. 
Holly80 and Norn81 both acknowledged that instillation of fluorescein does affect the volume of the 
tear film, and may affect the stability due to contamination of the tear film with fluorescein. 
Mengher82 found that the instillation of fluorescein had a significant effect on the TBUT, resulting in 
a quicker observed break-up; however, a later study by Cho83 could not replicate Mengher’s results 
and showed no difference in TBUT whether or not fluorescein was instilled. As an alternative to the 
conventional TBUT, Mengher proposed the measurement of tear break-up using a grid that is 
projected onto the cornea.84 This non-invasive measurement could be performed without the use of 
fluorescein, and was executed by timing the interval between a blink and the first distortions observed 
in the grid pattern. He named the procedure, quite appropriately, the non-invasive tear film break-up 
time (NIBUT).84 
 Tear-film interferometry has also been used as an alternative non-invasive technique to 
measure tear stability.85-88 King-Smith developed a complex optical system that generates narrowband 
and broadband images of the pre-corneal tear film via infrared retroillumination of the corneal 
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surface.89 The broadband images capture the overlying lipid layer, and when combined with the 
narrowband images corresponding to the aqueous tear layer, a full-thickness image of the tear film is 
generated. The observation of local changes in tear film thickness correlate to regional tear break-up, 
and can therefore be used as a highly sensitive method of measuring tear stability. Interferometry has 
the added advantage of precisely observing the local and global dynamics of tear break-up.88 
An indirect non-invasive measure of tear stability is the application of dynamic aberrometry 
of the ocular surface.90-92 A smooth, even tear film is known to provide optimal visual clarity,93 and as 
the tear film destabilizes and breaks up, a measurable decrease in an individual’s function acuity can 
be observed.94 Using this knowledge, wavefront analysis has been adapted to measure tear break up 
by detecting abrupt changes in the higher order aberrations of the ocular surface during the interblink 
interval. Koh was the first to use a Hartmann-Shack aberrometer to measure tear break up in 20 
normals and found almost a 1.5 times increase in higher order aberrations after tear film break-up,21, 91 
a result that was later replicated in a dry eye group.92 The primary disadvantage of the use of 
Hartmann-Shack aberrometry to measure tear stability is that the process is pupil-limited, meaning 
aberrations that occur outside the pupil cannot be measured. 
 A cut-off value for tear break-up time in the discrimination between normals and those with 
dry eye was recommended as <10 seconds soon after Norn’s first work,95 and Cho96 notes that despite 
a lack of evidence supporting its use, this value has remained entrenched in the literature. Vitali, using 
fluorescein TBUT, found a sensitivity of 72% and specificity of 62% when <10 seconds was used as 
a cut-off.97 When NIBUT was used with the same cut-off, sensitivity and specificity was shown to be 
slightly higher at 83% and 85% respectively.84 However, the positive predictive value in both studies 
was less than 50%,84, 97 perhaps not surprising knowing the large variability in individual TBUT 
results96 and the established poor repeatability of the test.98-99 Despite the pitfalls, evaluation of TBUT 
remains the most clinically feasible estimate of tear stability. 
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1.6 Tear osmolarity 
Osmometry is essentially the measure of the concentration of solutes within a solvent, and 
takes into account the disassociation of solutes in solution, irrespective of their size, density, 
molecular weight or electric charge.87 In the case of the tear film, the osmolarity is primarily 
determined by the content of various cations (including sodium, potassium, calcium and magnesium) 
and anions (chlorides, phosphates and bicarbonates), the predominant component being sodium 
chloride.88 Tear film proteins also contribute to the osmolarity, although their low concentration 
means their contribution is negligible.89 The terms osmolarity and osmolality are often used 
interchangeably in the literature, despite having very different meanings. Osmolarity is an expression 
of tonicity according to the number of moles per litre of solution (Osm/L), while osmolality describes 
the number of moles per kilogram (Osm/kg).90 The low protein content of tears means that molarity is 
about 5% lower than molality,88 but for clinical purposes, they are considered equivalent. 
A hyperosmolar tear film is thought to be responsible for the symptoms, inflammation and 
ocular surface damage associated with dry eye.23, 91-94 Its association as an end-result of both ADDE 
and EDE make it an ideal candidate as a diagnostic and screening test for the presence of dry eye. The 
recognized importance of tear osmolarity has necessitated the modification and development of 
sensitive instrumentation capable of measuring tear film tonicity, including the Clifton™ and 
Advanced Instruments 3100™ (freezing-point depression osmometers), the Wescor™(vapour-
pressure osmometer) and the TearLab™ (an electrical conductance osmometer). 
1.6.1 Freezing-point depression osmometers 
The early work on the characterization of tear osmolarity in health and disease by Farris, 
Gilbard, and Hill used the Clifton™ osmometer, an instrument which uses the freezing-point 
depression technique to determine osmolarity.100, 103-104, 108-110 Freezing-point depression is based on 
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the knowledge that the addition of a solute to a solvent will reduce its chemical potential, resulting in 





where ΔT represents the magnitude of the temperature depression below 0°C, and -1.86 is the 
cryoscopic constant for water.111 The cryoscopic constant is derived from the knowledge that one 
mole of solute will depress the freezing point of one litre of water by 1.86°C.111 This highlights how 
sensitive a freezing-point depression osmometer must be to variations in temperature, as an 
osmolarity of 300mOsm/L depresses the freezing point a mere 0.00558°C. The Clifton osmometer is 
capable of measuring osmolarity on volumes as small as 100nL, and consists of a sample holder 
embedded into a cooling stage and a controller box for the adjustment of the temperature of the unit. 
A microscope is also used to view the samples throughout the freezing process. Using the Clifton™, 
osmolarity values for normals have ranged between 302 mOsm/L100 and 318 mOsm/L,109 and for 
those with dry eye, values between 324 mOsm/L112 to 365 mOsm/L104 have been obtained. 
Although accepted as a gold-standard instrument, the Clifton™ osmometer is a large, 
complex instrument with the requirement of a specially-trained technician for its operation, and 
because it is no longer manufactured, its use for the measurement of tear osmolarity is becoming 
increasingly rare. The Advanced Instruments 3100™ osmometer, which also uses freezing-point 
depression, has been advocated as a replacement due its smaller size, an automated user-interface, and 
the requirement of only 500nL of tears for analysis. As it is a relatively new instrument it has not 
been used extensively, meaning little data is available on its performance. Dalton compared 
osmolarity values between those with mild-moderate dry eye and age-matched controls, and found a 
mean osmolarity of 312 mOsm/L in the dry eye group and 305 mOsm/L in the control group, a 




Figure 1-2. Image of Advanced Instruments 3100™ osmometer on left. The image at right 
displays various stages of the freezing (A – C) and thawing (D – E) process used to calculate 
sample osmolarity. 
1.6.2 Vapour-pressure osmometers 
 Above the surface of a solution, molecules of solvent are present in the gaseous phase. 
Sealing the solution in a vessel, such as the measurement chamber in a vapour pressure osmometer, 
will bring the liquid and vapour phases of the solvent into equilibrium and bring the solvent vapour 
pressure to a stable value. Under these conditions, the chemical potential of the solution’s solvent can 
be determined by comparing its vapour pressure to that of a pure solvent contained within a reference 
chamber.111 Addition of solute to a solvent reduces the solvent’s vapour pressure and increases the 
osmotic pressure, and hence osmolarity, of the solution formed by this addition. The Wescor™ 
osmometer does not actually measure vapour pressure. Rather, it determines the solvent activity of a 
solution, which is directly proportional to the vapour pressure.114 To initiate a measurement, two 
solutions are introduced to two separate chambers – one being the sample, the other being a reference 
sample, which is usually pure water. The instrument determines the dew point of each solution then 
calculates the osmolarity of the sample based on the difference between dew point temperatures. An 
important limitation of the Wescor™ osmometer is it requires a minimum sample volume of 1000nL 
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(1µL) to obtain a reading, which is a considerable volume to collect in a subject with ADDE or EDE. 
Some work has been done to demonstrate that volumes as small as 500nL can be used, but this has 
only been shown in an in vitro experiment using simple control solutions.115 For this reason, it is 
rarely used as a tear osmometer. Karkkainen et al. used the Wescor™ in 100 habitual contact lens 
wearers with no symptoms of dry eye and found a mean osmolarity of 297 mOsm/kg.116 
 
Figure 1-3. Image of the Wescor™ vapour-pressure osmometer. 
 All freezing-point depression and vapour-pressure tear osmometers suffer from limitations in 
their collection techniques, as both require a fairly invasive method of collecting tears that is apt to 
induce a reflex response, artificially lowering tear osmolarity values. Gilbard100 suggested the use of a 
glass micropipette with the aid of a biomicroscope, a tedious and time-consuming way of performing 
a collection, but still the predominant collection technique even today.108, 113, 116-121 This method runs 
the risk of inducing a reflex response not just from the repeated contact of the micropipette to the 
ocular surface, but also in response to the light of the biomicroscope. A second source of error with 
these methods is the need for sample transfer and storage, as measurement times with the instruments 
ranges between 80 seconds (in the case of the Wescor™) to 11 minutes (in the case of the Advanced 
Instruments 3100™ osmometer). This leaves samples susceptible to evaporation, which may inflate 
osmolarity values. Nelson and Wright evaluated both sources of error, and found that reflex tearing 
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and storage did have an effect on osmolarity values.122 To mitigate these confounding variables, a 
method for the indirect measurement of tear osmolarity using electrical conductance has been 
proposed.123 
1.6.3 Electrical conductance 
 Ogasawara et al. first described the use of a flexible conductimetric sensor that could be 
placed directly on the eye to measure the conductivity of the tear film.123 The micro-sensor was 
minimally-invasive, therefore avoiding a reflex tearing response, and the measurement could be 
performed in real-time, meaning a tear sample did not have to be collected from the eye for analysis. 
The conductivity of a fluid is a function of the concentration of ions present, and therefore a 
reasonable estimate of osmolarity. As the ion concentration increases, the resistance to the flow of 
electrons decreases, which can be interpreted as an increase in osmolarity. In that same study, 
osmolarity was measured as 296 mOsm/L in normals, and 325 mOsm/L in those with dry eye, 
demonstrating the potential validity of the technique for measuring tear osmolarity.123  
 Capitalizing on this concept, the TearLab™ is a handheld nano-osmometer capable of 
measuring osmolarity on 50 nL sample volumes by measuring electrical conductance. The system 
consists of a docking station and a pen, to which a chip card is attached. The tip of the chip card is 
placed into the tear meniscus, and a small channel within the chip card uses capillary action to draw 
up the tear sample. When the sample is collected, the pen is returned to the docking station for 
analysis. Analysis is performed by passing an electric current through the tear sample, and the 
resistance to the flow of current is measured and converted to an osmolarity value. The collection 
time is approximately 5 seconds, and analysis time is less than 20 seconds, making it an incredibly 
efficient process relative to previous osmometers. Tomlinson has done work comparing the 
TearLab™ to the Clifton™, and found osmolarity in controls was 308 ± 6.2mOsm/L (TearLab™) and 
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310 ± 7.2mOsm/l (Clifton™) and for those with dry eye 321 ± 16.5 mOsm/L and 323 ± 14.7 
mOsm/L, results that showed good agreement using Bland-Altman analysis.120 
 
Figure 1-4. TearLab™ unit and collection technique with the handheld pen and chip card. 
Gilbard and Farris’ were the first to suggest a cut-off between normal osmolarity and 
hyperosmolarity, which they believed to be 312 mOsm/L based on the findings of their first 
collaboration.100 Lucca et al., also using 312 mOsm/L as a cut-off, found a sensitivity and specificity 
of 90% and 95% respectively for the discrimination between those with dry eye and normals.124 
However, later work by Nelson found that using 312 mOsm/L as a cut-off had only 44% sensitivity 
and 75% specificity,125 perhaps not surprising because the earlier work used osmolarity as entrance 
criteria, biasing their cut-off.100, 124 Since that time, a range of cut-offs have been suggested, with 
differences attributable to variations in population, entrance criterion and instrument characteristics. 
The Pisa Criteria for dry eye determined that mild hyperosmolarity was 320 mOsm/L, moderate was 
330 mOsm/L and severe was anything greater than 340 mOsm/L.126 Craig recommended a cut-off of 
320 mOsm/L,127 and Sullivan128 and Mathers129 both suggested that 318 mOsm/L would be a 
reasonable value. As Tomlinson noted, the difficulty with selecting an appropriate cut-off lies in the 
fact that there is often a significant degree of overlap between osmolarity values in normals and those 
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with dry eye, particularly in the 300 – 320 mOsm/L range.130 Taking a different approach, Tomlinson 
and Khanal performed a meta-analysis of the literature with the hope of determining a referent that 
would maximize sensitivity and specificity.130 They arrived at a cut-off value of 315.6 mOsm/L, and 
when applying this cut-off to an independent sample, found it to have a sensitivity and specificity of 
59% and 94%, respectively.130 The positive predictive value was also high, leading them to suggest a 
cut-off of 316 mOsm/L, a referent that remains popular.131 
1.7 Tear meniscus height 
The volume of tears present on the ocular surface has been estimated to be 6.2 µL132 and is 
regulated by three factors: production of aqueous by the lacrimal gland, drainage via the nasolacrimal 
duct, and evaporation from the ocular surface. An impairment of aqueous production and/or increase 
in evaporation may reduce tear volume, ultimately increasing the risk for development of dry eye. For 
this reason, measurement of tear volume has been indicated as a clinically useful measure to assist in 
the diagnosis of dry eye.131 Perhaps the most commonly used test is the Schirmer I test, due to it being 
a relatively easy and accessible estimation of tear volume. The test is performed by placing a strip of 
filter paper into the lower conjunctival sac of each eye, and measuring the length of the strip that wets 
after 5 minutes. A positive test result is when the wetting length is <5mm, although cut-off values 
between 3mm117 and 10mm97 have been cited. Despite its common use, one survey revealed that 74% 
of ophthalmologists did not believe that the Schirmer I should be a standard of care.133 This clinical 
scepticism is related to the demonstrated poor reliability of the test,134-135 in addition to the myriad of 
extrinsic factors that can influence results, including the use of anaesthetic,136 an open versus closed 
eye,137 and evaporation.138 An alternative to the Schirmer test is the phenol red thread test (PRT), 
which uses a small cotton-thread impregnated with a red dye that is placed into the lower eyelid 
marginal zone for 15 seconds. This test is preferred because it induces less of a reflex response and 
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better predicts the basal tear volume. Nonetheless, PRT also suffers from the poor repeatability99, 135 
and sensitivity139 observed with the Schirmer I. 
 The tear meniscus has been estimated to contain 75-90% of the volume of tears on the ocular 
surface,140 and therefore measurement of meniscus parameters, particularly meniscus height, is 
predicted be a sensitive indicator of tear volume. The tear meniscus height (TMH) is defined as the 
vertical difference between where the tear film meets the globe and the upper or lower lid. Most 
often, the lower tear meniscus is imaged, as it is easiest to view and is not obscured by the lashes, as 
is the case with the upper tear meniscus. Eugene Wolff, presumably using a slit-lamp to view the 
meniscus en face (although his method was not adequately reported), was one of the first to publish 
on the lower tear meniscus height, stating that the average was ≥1 mm.141 As time has advanced, so 
have the techniques applied to TMH evaluation, and some of the more frequently reported include a 
slit-lamp/graticule combination,142-146 optical pachymetry,147-148 video capture147, 149-153 and optical 
coherence tomography(OCT).147, 154-162 
 
 
Figure 1-5. Image of the tear meniscus as taken with a slit-lamp and (A) white light (B) white 
light with sodium fluorescein instilled in the tears and (C) cobalt blue light in combination with 
a Wratten filter and sodium fluorescein instilled in the tears. The tear meniscus height is 




1.7.1 Slit-lamp and graticule/video capture 
The slit-lamp and graticule method is the most feasible of all the techniques for use in clinical 
practice due to ease of use and accessibility of the required instrumentation. A variation of this 
method is the use of video capture, whereby images of the TMH obtained from the slit lamp are 
recorded. These recorded images can either be displayed on a screen and manually measured149-151 or 
still images can be outputted for analysis using a variety of software.147, 152-153 There are a number of 
procedural differences regarding how these methods should be performed, including whether or not 
fluorescein should be used to aid visualization, whether the TMH is viewed as a cross-section or en 
face, and even how best to define the borders of the meniscus. The use of fluorescein is controversial 
because instillation of fluorescein will increase the tear volume, and thereby artificially inflate the 
TMH. In addition, there has been some suggestion that fluorescein destabilizes the tear film,82 which 
may influence TMH results. Johnson and Murphy explored the effects of fluorescein on TMH and 
found that 3 minutes after instillation of 5 µL of 2% fluorescein solution, TMH values had returned to 
baseline, a trend that was maintained to the 5 minute mark.147 They concluded that any TMH 
measurements that use fluorescein should be delayed 5 minutes to minimize any effect, although 
Garcia-Resua found that waiting 5 minutes allowed too much fluorescein to drain away from the 
ocular surface.163 Therefore, a more appropriate waiting time after instillation may be 3 minutes to 
maximize fluorescence, while negating effects on the TMH. The meniscus has been reported to be 
viewed from the front143, 145 or as a cross-section146 and there is some evidence to show that cross-
sectional imaging does result in a larger measurement.147, 152-153 This has been hypothesized to be a 
result of cross-sectional imaging enabling better visualization of the tails of the meniscus.147 The top 
of the meniscus has also been defined as the point at which it is maximally reflective,148, 163 known as 
the TMH-R, but this will yield a smaller result than the more commonly accepted definition of the 
meniscus outlined earlier. Because of the many variations in this technique, there is a range of values 
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that have been reported for slit-lamp/graticule-measured TMH in normals. In a brief summary of the 
available literature, Doughty noted a range from 0.15 – 0.46mm, and an average TMH of 0.245mm 
from 13 reports.151 
1.7.2 Optical pachymetry 
When using the slit-lamp graticule method, minute eye movements, in addition to only being 
able to measure in 0.1mm steps, may limit the accuracy of measurements. With this in mind, Port 
modified a Haag-Streit optical corneal pachometer to measure TMH.148 The pachometer required a 
custom mounting bracket to position it 90° to where it would normally be positioned to measure 
corneal thickness, allowing a vertical doubling of the image to be achieved. A disadvantage of this 
method is that it is difficult to visualize the fine tails of the meniscus frontally, and therefore the 
authors decided to measure the TMH-R. They found a mean TMH of 0.18mm for measures taken en 
face at the central lower lid in 66 control eyes, a value that is a slight underestimation due to the use 
of the TMH-R. Using the same technique, Johnson and Murphy measured TMH in cross-section with 
and without fluorescein, and en face with fluorescein.147 Their mean TMH for en face viewing was 
0.31mm, much higher than Port’s, and was due to the added fluorescein allowing better visualization 
of the complete meniscus. Cross-sectional viewing yielded a slightly higher TMH at 0.38mm, and the 
authors noted that viewing the meniscus was easiest using this method. Nonetheless, they advocated 
the use of en face over cross-sectional viewing due to increased repeatability.147 Although optical 
pachometry has demonstrable value for TMH measures, its use will likely be confined to research, as 
the requirement for a custom-mounting makes its implementation difficult. 
1.7.3 Optical coherence tomography 
A review of the recent literature makes it apparent that OCT is becoming the preferred 
method for the measurement of TMH (Table 1). OCT is non-invasive, does not require the instillation 
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of fluorescein, and gives a cross-sectional, high resolution view of the meniscus, making it in many 
respects superior to the previously outlined techniques. Izatt was the first to publish on the use of 
OCT to image the anterior segment in vivo in 1994, and suggested OCT would be beneficial for 
evaluation of the cornea and other anterior segment structures.164 Eight years later, Jones et al. were 
the first to document the ability of OCT to image the lower tear meniscus.165 
 OCT is based on measuring the reflectance of light from different layers of an object to create 
cross-sectional images, akin to a B-scan ultrasound. Light in an OCT system, typically from an 
infrared superluminescent diode, is passed through a beam-splitter and broken into two arms – a 
sample arm and a reference arm. The light from the sample arm is directed at the object of interest, 
and any reflected light is coupled back into the sample arm to be recombined with the reference arm. 
The combination of reflected light from the sample arm and reference light from the reference arm 
results in an interference pattern. By scanning a mirror in the reference arm, a reflectivity profile of 
the sample can be obtained, as is the case with time-domain OCT. It is the reflectivity profile, more 
commonly known as an A-scan, which contains information about the spatial dimensions and location 
of structures within the object of interest. By combining multiple A-scans, a two-dimensional 
representation of the object of interest can be created. 
 There are two types of OCT that are currently commercially-available: time-domain (TD-
OCT) and Fourier-domain (FD-OCT). As noted above, TD-OCT relies on the movement of a 
mechanical mirror in its reference arm to produce a reflectivity profile. With FD-OCT, the reference 
mirror is stationary, and instead a spectral pattern is derived from the interference generated between 
the reference and sample arm. This spectral pattern undergoes Fourier transformation to produce the 
A-scan. The advantage of FD-OCT over TD-OCT is the use of a stationary reference mirror, which 
removes mechanical limitations and allows faster scanning times. For example, the fastest TD-OCT 
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can obtain 2000 A-scans per second, while the fastest FD-OCT is capable of generating 26000 A-
scans per second. 
There are two characteristics of OCT that make it well-suited for TMH measurement. As 
mentioned earlier, the wavelength of light used by OCT is in the infrared spectrum, and is usually 
800-900nm for retinal OCTs and 1300nm for anterior-segment OCTs (AS-OCT). This is particularly 
advantageous for the measurement of TMH, as infrared light will not dazzle subjects like white light 
from a slit lamp will. This eliminates a possible stimulus of reflex tearing, thereby avoiding any 
influence on the TMH. A second advantage of OCT is the resolution, reported to be between 2 and 
20µm. Increased resolution presumably allows for greater accuracy in defining the boundaries of the 
meniscus, and also provides a larger range of measurement values (i.e. OCT can measure in 0.01 – 
0.001mm steps versus a graticule, which is limited to 0.1mm steps). 
 Retinal-OCTs were the first machines used to measure TMH, as the first AS-OCTs weren’t 
readily available until 2005. Johnson147 and Srinivasan,158 both using a first-generation OCT, 
observed a mean TMH of 0.27mm  and 0.162mm respectively in normals. A third-generation OCT 
(Stratus) used to measure TMH on 20 normals yielded a mean of 0.25mm,162 in close agreement with 
the work of  Johnson. Because these early OCTs were intended for retinal use, they did not have 
integrated software capable of analysis of the images. As such, images were exported to third-party 
software such as PowerPoint,147 Adobe Photoshop,162 or custom-software158 for measurement, which 
may explain some of the differences observed between studies. Johnson also noted that analysis of 
images from these early instruments was difficult due to confusion discerning where the eyelid/cornea 
and tears came together, which he attributed to poor resolution resulting in pixelated images.147 This 
led to arbitrary locations being picked for the tails of the meniscus and lowered test repeatability. 
However, other work has shown that training sessions on defining where the meniscus boundaries are 
located can eliminate variability in image analysis, and improve repeatability.166  
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With the growing interest in the use of OCT for the evaluation of the anterior segment,167 a 
number of papers have evaluated the ability of AS-OCT, using either the Visante, the RTVue-100, or 
a custom-OCT, to measure the TMH.71, 154-157, 159-161, 168-169 A comparison study between the Visante 
and Stratus revealed significant differences between the two instruments, with the Visante biased by 
an average of 0.05mm greater than the Stratus. Mean TMH values in control groups reported in other 
studies, 0.331mm71 and 0.40mm,155 are also higher than those reported using retinal-OCTs.147, 158, 162, 
166 Similar trends in TMH values are observed using the RTVue-100 FD-OCT, a retinal-OCT with 
interchangeable lenses that render it capable of capturing images of the anterior segment. Kim et al. 
used the RTVue-100 to image both lower menisci in those who had undergone anophthalmic surgery 
in one eye, and found that the meniscus along the prosthetic eye was significantly lower than the non-
operated eye (0.200mm and 0.261mm, respectively).168 Zhou used the same instrument to evaluate 
TMH in 20 normal subjects and found a mean of 0.285mm.161 Wang has developed a custom AS-
OCT that is capable of imaging both the upper and lower meniscus simultaneously in real-time.169 It 
has been used in a variety of studies that have used TMH measures to understand tear dynamics, and 
TMH values in control groups have ranged between 0.240mm and 0.339mm.154, 157, 159-160 The trend 
towards increased measures of TMH using AS-OCT versus retinal-OCTs may be secondary to 
dewarping algorithms that AS-OCTs employ as a means of converting the image from optical space 
to physical space. A dewarping calculation consists of two factors: a shape factor and distance 
factor.170 When the scan beam length of the AS-OCT is greater than 3mm, it is unlikely that all 
incident beams from the OCT will be perpendicular to the corneal surface. This results in bending, or 
warping, of light which must be compensated for using the shape factor. The distance factor relates to 
the refractive indices of the target tissue. To make correct physical distance measurements, 
dimensions measured must be divided by the refractive index of the media. 
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Table 1 briefly summarizes papers published between 2007 and 2010 that have evaluated 
TMH measures in either controls and/or those with dry eye. The mean TMH in normals for the 15 
papers is 0.266mm, and falls in between the mean reported in Johnson and Murphy’s review of TMH 
literature in 2005 (0.28mm),147 and that reported by Doughty in 2002 (0.245mm).151 It is interesting to 
note that if one only considers those published results that have used AS-OCTs, the average TMH 
jumps to 0.295mm. The gradual increase in TMH values may be related to the concurrent 
improvement in image quality and resolution that newer instruments are capable of. The current 
generation of OCTs, particularly FD-OCTs, have a resolution that is considerably higher than other 
imaging techniques, making it easier to define the meniscus borders. Meniscus parameters that are 
easier to identify should also result in improved repeatability, and studies have shown that the 




Author Year Method Control (n) 
Control, mm 
(mean ± SD) 
Dry eye 
(n) 
Dry eye, mm 
(mean ± SD) 
Ibrahim et al.155 2010 OCT (Visante) 27 0.40 ± 0.17 24 0.25 ± 0.08 
Yuan et al.160 2010 OCT (Custom) 30 0.268 ± 0.097 25 0.227 ± 0.093 
Chen et al.154 2010 OCT (Custom) 20 0.251 ± 0.036 20 0.192 ± 0.029 
Shen et al.157 2010 OCT (Custom) 35 0.240 ± 0.053 
 
Koh et al.71 2010 OCT (Visante) 11 0.331 ± 0.085 




graticule 34 0.250 ± 0.08 
Zhou et al.161 2009 OCT (RTVue-100) 20 0.285 ± 0.08 
Savini et al.156 2008 
OCT 
(Visante) 26 0.28 ± 0.12 
OCT (Stratus) 0.23 ± 0.07 
Bitton et al.171 2008 OCT (OCT2) 15 0.117 ± 0.03 15 0.143 ± 0.05 
Harrison et al.172 2008 Slit-lamp w/ mm ruler 15 0.40 ± 0.09 15 0.30 ± 0.07 
Wang et al.159 2008 OCT (Custom) 36 0.339 ± 0.149  
Srinivasan et al.158 2007 OCT (OCT2) 20 0.142 ± 0.016 20 0.133 ± 0.012 
Uchida et al.173 2007 TearScope 17 0.22 ± 0.065 27a 0.13 ± 0.042 
Kawai et al.174 2007 Slit-lamp w/ fluorescein 19 0.24 ± 0.08 14 0.17 ± 0.07 
 MEAN 0.266mm  0.193mm 
 
a = dry eye group consisted solely of those with Sjögren’s syndrome 
Table 1-1. Tear meniscus height values reported in the literature between 2007 and 2010 for 
normals and those with dry eye. 
 Various studies have commented on the utility and cut-off values for TMH measures in the 
diagnosis of dry eye. Lamberts suggested that a cut-off of <0.1mm was suitable for the diagnosis of 
dry eye based on the finding that over 93% of TMH values were greater than 0.1mm in 86 normals. 
On the opposite extreme, Mainstone used a video-capture to determine that a cut-off of ≤0.35mm had 
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93.3% sensitivity and 66.7% specificity. The range of cut-off values is reflective of the variation 
observed in TMH measures between studies, making it difficult to select a value with appropriate 
predictive value. The mean TMH in the dry eye group from Table 1 is 0.193mm, which might suggest 
that a cut-off of approximately 0.2mm might be appropriate. However, with the apparent increase in 
measured TMH that is observed with the newer, and more frequently used AS-OCTs, 0.2mm may 
result in under-diagnosis of dry eye. One advantage of the increasing use of only two instruments for 
TMH measurement is that there will be more consistency in the analysis techniques employed by 
different studies, as both the RTVue-100 and Visante have standard integrated analysis software. This 
may lead to a more universally accepted cut-off being derived in the future. Regardless, TMH 
demonstrates acceptable sensitivity and specificity155, 157, 175 to be a valuable test in the diagnosis of 
dry eye. 
1.8 Conclusion 
 As the DEWS definition of dry eye states, dry eye is a complex, multi-factorial disease that 
involves dysfunction of the tear film on multiple levels.24 This complexity makes it incredibly 
difficult to correctly diagnose dry eye, as there are multiple aspects of the lacrimal functional unit to 
consider. The ideal test for the screening and diagnosis of dry eye would have high sensitivity and 
specificity, in addition to a high positive predictive value. More importantly, it would be easy to 
perform in a clinical setting, with minimal instrumentation and maximum efficiency. As practitioners, 
we often rely heavily on a patient’s subjective complaints to make the diagnosis. However, objective 
tests add information regarding severity and possible aetiology, which factor significantly when 
trying to plan treatment or chart the progress of the disease.  
The TMH has been indicated as a clinically useful estimate of the volume of the tear film.25 If 
done without the use of fluorescein, it is non-invasive, and it has been shown to have relatively high 
sensitivity and specificity for the diagnosis of dry eye.155, 157, 175 For the aforementioned reasons, OCT 
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is ideally suited to measure TMH, and its high resolution and integrated software presumably make 
the measurement process easier and more accurate. Although TMH is a valuable objective test that 
can aid in the diagnosis of dry eye , changes in our understanding of the condition is leading to other 
tests that may have greater sensitivity and specificity. It has been suggested the majority of symptoms 
and signs of dry eye are primarily due to hyperosmolarity of the tear film.104, 118 Because of this, 
osmolarity has been postulated to be the new “gold standard” for the diagnosis of dry eye, and Khanal 
showed that tear osmolarity performed well as a single diagnostic test for the diagnosis of dry eye.176 
However, a number of factors have prevented osmolarity from becoming a standard clinical test in the 
diagnosis of dry eye, namely the need for large sample volumes that are invasively collected, bulky 
and complex instrumentation, and inefficient analysis methods. The TearLab is poised to become the 
first instrument capable of measuring tear osmolarity in a non-invasive, time efficient manner, but 
little is known about its performance and capabilities. 
The following chapters present data on measures of tear film parameters using two new 
technologies, the RTVue-100 FD-OCT and the TearLab nano-osmometer. Of particular interest is 
each instrument’s performance in both the normal and dry eye population. 
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Tear Meniscus Height Determination Using the OCT2 and  
the RTVue-100 
2.1 Introduction 
It is well-established that the ocular surface requires a certain volume of tears to maintain a 
trophic environment. The tear film bathes the ocular surface, freeing it from debris, supplying 
valuable nutrients and maintaining a stable refractive interface.1, 2 Deviations in the volume can lead 
to symptoms of ocular discomfort, including burning, foreign body sensation, ocular fatigue and 
visual blurring.3 Despite the importance of tear volume, there is a distinct lack of test availability that 
can accurately quantify tear volume. Currently, one of the most commonly used methods is the 
Schirmer I test, although it has been shown to have poor diagnostic sensitivity4 and repeatability.5 
Another disadvantage of the Schirmer I test is its invasive nature, which has the potential to 
compromise any results via the induction of reflex tearing. 
With this in mind, the tear meniscus height (TMH) has been indicated as a clinically useful 
estimate of the volume of the tear film.6 If done without the use of fluorescein, it is non-invasive, and 
its has been shown to have relatively high sensitivity and specificity.7 Methods of measuring TMH 
have included the graticule method,8-10 image capture,11-14 optical pachymetry,10, 15 and optical 
coherence tomography (OCT).7, 16-20 The use of OCT is becoming increasingly widespread because of 
the high resolution images that it produces, which makes analysis easier and, presumably, more 
accurate. The majority of published results on measuring the TMH using OCT have used 
conventional time-domain OCT (TOCT).16-20 Recently, Optovue Inc. released a commercially 
available spectral-, or Fourier-, domain OCT (SOCT) capable of imaging the anterior segment. SOCT 
provides a higher resolution image that can be captured in a short time frame compared to TOCT. It 
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uses two lens attachments, the Cornea/Anterior Module-Short (CAM-S) and CAM-Long (CAM-L) to 
obtain anterior segment images. The CAM-S attachment provides a high magnification view, while 
the CAM-L provides a wider viewing angle but a slightly decreased resolution (Figure 2 – 1). In 
addition, integrated analysis software is provided, which obviates the need for the data to be exported 
to third-party software for subsequent analysis.16, 18, 20, 21 
The purpose of this study was to compare TMH measurements obtained using TOCT (OCT2, Carl 
Zeiss Meditec, Dublin, CA, USA) to SOCT (RTVue-100, Optovue, Freemont, CA, USA). 
 
Figure 2-1. Native image of corneal scar taken with the RTVue-100 CAM-L lens (A) and CAM-
S lens (B). The CAM-S lens provides higher magnification, while the CAM-L lens produces an 
image with a wider field of view but reduced magnification. 
2.2 Methods 
The protocol used for this study received ethics approval from the Office of Research Ethics 
at the University of Waterloo. 50 healthy subjects (16 males and 34 females) with a mean age of 33.2 
years (range 19-62 years) were recruited to participate in the study. Subjects were excluded from the 
study if they had a history of refractive surgery, exhibited the presence of conjunctivochalasis, had 
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worn contact lenses in the past 12 hours, or used artificial tear drops over the previous 6 hours. All 
subjects gave their informed consent according to the Declaration of Helsinki.  
The same examiner (AK) imaged the lower TMH of the right eye in all patients using both 
the OCT2 and the RTVue-100. Three scans were taken using the OCT2, and six scans were taken 
using the RTVue-100, three using the CAM-S lens and three using the CAM-L lens. The order in 
which the scans were carried out was randomized. A small mark was placed below the lash margin of 
the lower right lid at approximately the 6 o’clock position to ensure that the scans were completed in 
the same position using all imaging modalities. When applying the mark, care was taken to ensure 
that no contact was made with the ocular surface, thereby avoiding interference with the normal tear 
film. 
The nine scans were performed consecutively within a ten-minute period in a temperature 
(25°C ± 1°C) and humidity (13% ± 2%) controlled room. Both instruments were placed in the same 
room, side-by-side, to expedite the measurement session. The lights were dimmed and equipment 
moved away from ventilation ducts to avoid the induction of reflex tearing. Patients were asked to 
look straight ahead and blink as necessary to avoid ocular surface desiccation. 
The settings and methods used to image and analyze the TMH with the OCT2 have been 
described elsewhere.20 Briefly, a beam of 1.13mm vertical height was focused onto the ocular surface 
centered within the lower lid marking. We attempted to capture the images within the first second 
immediately following a blink. The raw image data were exported to proprietary analysis software 
capable of measuring the TMH, where it was analyzed by a masked examiner. The height of the 
meniscus was taken as the vertical difference between the point at which the tail of the meniscus 
intersected with the cornea superiorly and the lower lid inferiorly. The default scan settings were used 
on the RTVue-100 OCT, meaning a 2.0mm vertical beam was used with the CAM-S lens and a 
6.0mm vertical beam was used with the CAM-L. All image analysis was performed using the built-in 
 
 33 
calliper tool as part of the RTVue-100 software package using the same criteria as described above to 
determine the TMH. 
After completing the study, both instruments were calibrated against two different slit-lamp 
graticules, each comprised of an internal ruler divided into 0.1mm intervals. The graticules were 
mounted onto a lens stand, and imaged using the OCT2, and CAM-S and CAM-L SOCT lenses using 
the settings outlined above. A 1mm section of each image was randomly chosen and ten consecutive 




Figure 2-2. A 2mm section of the graticule as imaged by the CAM-S lens. Due to excess noise 
levels when imaging the graticule surface with either of the SOCT lenses, the focal point was set 
ahead of the graticule, allowing the interval between reflections of the lines to be measured. 
2.3 Statistical analysis 
Analysis was performed using Statistica version 7 (StatSoft, Tulsa, OK, USA) and a free 
online statistical calculator.22 A repeated measures ANOVA was calculated to evaluate differences 
between the three instruments and to determine if a difference between measurement sessions existed, 
followed by analysis using Tukey’s Honestly Significant Differences (HSD) test. The relationship 
between the three measurement methods was analyzed by Lin’s concordance of correlation 
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coefficient23 and Bland-Altman analysis.24 A p value of less than 0.05 was considered statistically 
significant. 
2.4 Results 
Calibration testing showed that the mean interval measured on the first graticule using OCT2 
was 0.099 ± 0.013mm and 0.102 ± 0.006mm on the second graticule. The CAM-S lens measured 
0.099 ± 0.003mm/ 0.099 ± 0.001mm and the CAM-L measured 0.100 ± 0.003mm/0.100 ± 0.005mm 
for the mean interval of the first/second graticule respectively. Calibration also revealed that the scan 
height setting of 1.13mm produced a beam that was 1.40mm high. Based on this result, all measures 






Figure 2-3. Lin’s concordance of correlation coefficient comparing the OCT2 and CAM-L lens, 
ρc = 0.5566. Note that there is closer agreement between instruments for TMH values 
measuring between 100µ and 200µ, and the tendency of the CAM-L lens to give higher 
measurements as the mean TMH increases. 
The mean TMH as measured by the OCT2 was 0.280 ± 0.139mm, while the mean TMH 
measured using the CAM-S and CAM-L lens was 0.354 ± 0.163mm and 0.345 ± 0.167mm 
respectively. Bland-Altman analysis showed a low level of agreement with both the CAM-S and 
CAM-L lens in comparison to the OCT2. The 95% limits of agreement (LOA) ranged between -0.138 
and +0.285mm for the CAM-S and -0.185 and +0.315mm for the CAM-L. Lin’s concordance of 
correlation coefficient (ρc) was 0.6402 for the CAM-S and 0.5566 for the CAM-L (Figure 2 – 3). 
When comparing the CAM-S directly to the CAM-L, Lin’s CCC showed a high strength of 
agreement with ρc = 0.8944. Repeated measures ANOVA showed a statistically significant difference 
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between measures taken with the OCT2 and CAM-S (p<0.001) and OCT2 and CAM-L (p<0.001) 
(Figure 2 – 4). This result was confirmed using Tukey’s HSD, with a p<0.001 when comparing the 
OCT2 to the CAM-S and CAM-L respectively. A difference between the CAM-S and CAM-L lens 
was not demonstrated (p=1.0). There was not a statistically significant difference between the three 
measurements taken using each instrument (p=0.101), although the measured TMH did increase 
slightly from the first to third measurement. 
 
Figure 2-4. Repeated measures ANOVA showing poor agreement between the OCT2 and both 
the CAM-S and CAM-L (both p < 0.001) TMH measures. There was no significant difference 





The data analysis showed a significant difference between the measurements obtained with 
conventional TOCT as compared to SOCT. The OCT2 yielded a mean TMH of 0.280mm, while the 
mean TMH obtained using the CAM-S and CAM-L lens was 0.354mm and 0.345mm respectively. 
Although higher than the OCT2, the two SOCT results were concordant, and showed a high strength 
of agreement based on the results from Lin’s concordance correlation coefficient (ρc = 0.8944). 
Nonetheless, SOCT TMH measures were almost 20% higher than the results obtained with the OCT2, 
and do not agree with any published data on TMH obtained with OCT. There is only one other 
published result that looked at the ability of a commercially-available anterior segment OCT (AS-
OCT) to measure TMH.16 In that study, a mean TMH of 0.28mm was reported. Although our 
measured TMH was higher, it does point out that anterior segment-specific OCTs have thus far 
tended to yield a higher measured TMH when compared to traditional OCTs designed for posterior 
segment analysis. 
The difference in measured TMH between posterior segment OCT and AS-OCT has been 
postulated to be due to AS-OCTs using complex dewarping algorithms when converting an image 
from optical space into physical space.16 There are two aspects to the dewarp calculation: a shape 
factor and distance factor.25 When the scan beam length is greater than 3mm, it is unlikely that all 
incident beams from the OCT will be perpendicular to the corneal surface. The result is bending, or 
warping of light, which must be compensated for using a shape factor. The distance factor relates to 
the refractive indices of the target tissue. To make correct physical distance measurements, 
dimensions measured must be divided by the refractive index of the media. We suspect that the 
RTVue-100 performs one or both of these dewarping calculations, which may alter the processed 
image and artificially increase the measured TMH. However, without access to commercially-
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sensitive information about the design of the software and instrument, we are unable to definitively 
surmise this.  
A second explanation for the higher measured TMH using SOCT may be the increased 
resolution provided by SOCT. Figure 2 – 5A shows the image as obtained with TOCT. The large 
pixels make delineation of the borders of the meniscus difficult, and the examiner is often left making 
assumptions as to where the meniscus meets the cornea and lower lid. This same observation was 
made in an earlier paper, which showed that significant variation in image analysis can be present due 
to reduced resolution.20 Figure 2 – 5B shows an image obtained with the CAM-S lens that has been 
broken up into two zones, A and B. Zone A correlates with what is likely resolved in a conventional 
TOCT image and zone B shows the “fine tail” of the upper section of the tear meniscus . It is this 
zone that is plausibly indefinable in a TOCT image, and we surmise results in the higher 
measurement values obtained using SOCT. For example, in Figure 2 – 5B, zone B adds an additional 




Figure 2-5. TM of the same eye imaged using the OCT2 (A), CAM-S (B), and CAM-L (C). The 
images have been cropped and re-sized for comparison purposes, and magnification and scale 
are not equal for all three images. Figure 2-5B shows an image obtained with the CAM-S lens 
that has been broken up into two zones, A and B. Zone A correlates with what is likely resolved 
in a conventional TOCT image and zone B shows the fine tail of the tear meniscus . It is this 
zone that is plausibly indefinable in a TOCT image, and results in the higher measurement 
values obtained using SOCT. In Figure 2-5B, zone B adds an additional 223µ to the measured 
TMH. 
The high degree of variability between instruments as demonstrated by Bland-Altman 
analysis can likely be attributed to the dynamic nature of the tear film. Tear flow has been estimated 
to be 0.30µL/min and has a turnover rate of 16%/min.26 These factors, coupled with evaporative 
effects, will cause a degree of variability if measures are not taken at the same time point. We 
attempted to minimize this by taking the scan immediately after a blink. 
This study also highlights the importance of calibrating instruments and software before use. 
Failure to perform calibration would have resulted in the OCT2 mean TMH measuring 0.226mm, 
which is 25% lower than the calibrated measurement. Interestingly, it is the uncalibrated TMH that 
correlates well with other published results using similar instruments that had not been calibrated.16, 18-
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20 Bitton et al., also using a second generation OCT and the same custom measurement software, 
obtained a mean TMH of 0.24mm.20 A more recent study by Savini used the Stratus OCT and found a 
mean TMH of 0.23mm.16 Although some may question why an older OCT was chosen in this 
particular study, the fact that our uncalibrated TMH results found with the OCT2 concur with the 
Stratus should show the machines to be comparable. This is only the second study that the authors are 
aware of that have calibrated the OCTs used throughout the study to measure TMH.21  
SOCT demonstrated a number of advantages over conventional TOCT. Primarily, the 
increased resolution of the RTVue versus the OCT2 (5µ vs. 10µ) makes image analysis easier, 
because there is less discrepancy regarding the identification of the borders of the tear film, a problem 
identified in another study.20 This improves consistency in image analysis within and between 
observers. Secondly, the ease and speed with which an image can be captured is a significant benefit, 
as it is probably more reflective of the natural state of the tear film. The scan time of the RTVue is 
0.16 second, considerably shorter than the 1-2 seconds that it takes for the OCT2. This increased time 
to acquire the scan may also lead to evaporation of the tear film, reducing the volume, and hence 
TMH measurements, obtained with the OCT2. Another major advantage of the RTVue over OCT2 is 
the provision of integrated analysis software. This eliminates the need to export the images and does 
away with the need for development of software capable of analysis. It also allows for comparison 
and consistency during multi-center studies, as the software is standard on each instrument.  
Future research needs to establish the causative factors behind the differences in measured 
TMH between TOCT and SOCT. In the event that it is demonstrated that SOCT over-estimates TMH, 
it would be ideal if a correction factor could be derived that will allow for accurate measurements and 
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Impact of time between collection and collection method on human 
tear fluid osmolarity 
3.1 Introduction 
 In the early 1950’s, Balik first proposed, but was unable to demonstrate, a link between tear 
hyperosmolarity and keratoconjunctivitis sicca (KCS), or dry eye.1 Despite his failure to do so, the 
idea that increased osmolarity was a primary causative factor behind the development of dry eye 
persisted and throughout the 1970’s and 1980’s, Gilbard,2-6 Farris,2, 3, 5, 7-9 and Benjamin10-12 produced 
an immense amount of data on osmolarity values in normals and those with KCS. Their work 
provided the foundation for the Dry Eye Workshop (DEWS) report on the definition and 
classification of dry eye, which recognized tear hyperosmolarity as a core mechanism.13 Despite an 
established role, the measurement of tear osmolarity has not been routinely undertaken in clinical 
practice due to a number of technical limitations of the available instrumentation. 
 Much of the initial work by Gilbard and Farris was accomplished using the Clifton nanolitre 
osmometer [Clifton Technical Physics, Hartford, NY], which uses the freezing-point depression 
technique to determine osmolarity.2-4 Although a reliable instrument,14 it requires a trained technician 
to process samples and is too large to be used outside the realm of research. Vapor-pressure 
osmometry has also been used with some success,15-17 but is hampered by the requirement of large 
tear volumes to yield an accurate measurement. A major disadvantage of both instruments is the 
collection technique employed to gather a sufficient tear sample. The collection technique developed 
by Gilbard,18 and subsequently used by others,19, 20 uses a slit-lamp to guide a glass capillary tube into 
the lower meniscus to collect the tear sample. This method is invasive and apt to induce reflex 
tearing, secondary to mechanical or visible light stimulation of the eye.  
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 Ogasawara et al. devised a flexible sensor capable of measuring osmolarity by responding to 
the conductivity of the tear film, and used the technique to show an increased osmolarity in those 
suffering from KCS versus a control group.21 The primary advantage of measuring tear film 
conductivity over other osmometry methods is that the volume required is independent of the 
osmolarity, meaning a small volume is sufficient. This makes it an ideal methodology for tear 
collection in those suffering from aqueous-deficient dry eye. Building on Ogasawara’s work, in 2007 
TearLab released a handheld nano-osmometer capable of measuring tear osmolarity on 0.05 µL 
sample volumes. The device utilizes a unique chip card system which non-invasively collects and 
processes tear samples within 60 seconds. This collection technique overcomes two of the limitations 
of the glass capillary tube method. First, collection of a sufficient tear sample takes less than one 
second using the TearLab, thereby minimizing the potential influence of reflex tearing. Secondly, the 
analysis is performed within the chip card and the sample does not need to be transferred for analysis, 
which mitigates any evaporative effects. Although the TearLab appears to overcome a number of 
technical and methodological short-comings of other methods outlined above, little is known about its 
performance in a dry eye or normal population. The present study consisted of two-phases aimed at 
validating the use of the TearLab nano-osmometer in a clinical setting. Secondary outcome measures 
included the ideal time interval between consecutive collections that will yield reproducible results, 
and the effect that the collection method, namely glass capillary tube, has on tear film osmolarity. 
3.2 Methods 
The study received approval from the University of Waterloo’s Office of Research Ethics, 
and in adherence to the tenets of the Declaration of Helsinki, informed consent was obtained from all 
subjects before enrolment. Exclusion criteria for the study was the use of artificial tears six hours 
prior to any study visit, and participants were asked to refrain from wearing contact lenses while 
enrolled in the study. After subjects were enrolled, they completed the Ocular Surface Disease Index 
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(OSDI), a standardized questionnaire used to categorize subjects into dry eye or control groups.22 An 
OSDI score of ≥20 placed a subject into the dry eye group.  
During phase I of the study, 10 subjects were recruited into each of the control and dry eye 
groups. Subjects attended three visits over a five day period, with the time of each visit kept the same 
to eliminate any diurnal variations of the tear film. In the course of a given visit, eight tear collections 
were taken from each eye using the TearLab, the first four separated by a 15 minute interval, and the 
final four separated by a one minute interval. A 15-minute washout period was given between the 
fourth and fifth tear collection to allow the tear film to equilibrate. At the conclusion of the visit, a 
tear break-up time (TBUT) was measured on each eye in triplicate via instillation of sodium 
fluorescein. 
For phase II,15 subjects were enrolled into the control group and 15 into the dry eye group 
using the same criteria as above. The second phase consisted of four visits attended over a two week 
period. Eight tear collections were performed on each eye at each visit. The first four collections were 
performed using the TearLab and were collected a 90-second intervals. This was followed by a 15-
minute washout period, whereupon 5µL was collected from both the right and left eye using a glass 
capillary tube [Drummond Scientific, Broomall, PA, USA] (GCT). 
When collecting tears using the TearLab, subjects were instructed to direct their gaze 
superonasally, and the collection tip of the chip card was gently placed into the tear meniscus at the 
lateral canthus. The tip was moved in and out of the meniscus to stimulate the capillary action, care 
being taken to avoid contacting the ocular surface. After the sample was successfully collected, it was 
immediately returned to the docking station for measurement. The collection process using the GCT 
was similar to that of the TearLab. Subjects looked superonasal, and the tip of the GCT was placed 
into the tear meniscus at the lateral canthus. Care was taken to avoid contacting the ocular surface and 
lids; however, if the investigator (AK) or participant observed any reflex tearing, the collection 
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process was stopped for 90 seconds to allow for equilibration of the tear film. Collection continued 
until either 5µL of tear film was obtained or 7 minutes passed, the latter guideline used to minimize 
evaporative effects. When collection was completed, the sample was immediately transferred to 
0.1mL PCR tubes (Axygen Scientific Inc., Union City, CA, USA), spun down for 7 seconds at 
approximately 6500rpms, and placed on ice. Osmolarity of the tear sample was measured by 
transferring 500nL onto a clean 1” square of Parafilm (Pechiney Plastic Packaging Company, 
Chicago, IL, USA) and immediately collecting the dispensed sample with the TearLab. The 
measurement process was repeated four times on each tear sample. 
3.3 Statistical analysis 
Data from phase I and phase II was entered into Microsoft Excel spreadsheets (Microsoft 
Corp., Redmond, WA, USA) and subsequently exported to Statistica version 7 for analysis (Statsoft, 
Tulsa, OK, USA). The results generated in both phases from the TearLab and through the 
measurement of TBUT were evaluated using a repeated-measure ANOVA. A t-test was used to 
compare OSDI scores between control and dry eye groups. Relationships between variables, namely 
OSDI score, osmolarity and TBUT, were quantified through the use of Pearson’s correlation 
coefficients or non-linear regression analysis, and r > 0.60 was considered to be a significant 
correlation. The coefficient of variation (CV) was determined for both control and dry eye groups in 
phase I of the experiment at 15 minute and 1 minute intervals. Repeatability of osmolarity results for 
each time interval was assessed through the calculation of intraclass correlation co-efficients (ICC) 
for mixed models. A p-value equal to or less than 0.05 was considered to be statistically significant. 
3.4 Results 
Phase I enrolled four males and sixteen females for participation, with a mean age of 42.8 ± 
16.4 years (range 22 – 73). Mean osmolarity of the control group across all measures was 287.9 ± 7.5 
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mOsm/L and for the dry eye group, mean osmolarity was 297.8 ± 14.7 mOsm/L, which was 
significantly different (p=0.007) [Table 3 – 1]. OSDI scores and TBUT were also noted to be 
significantly different between the two groups (p<0.0001 and p=0.029). No significant difference was 
observed between left and right eye measures (p=0.202), 15 minute versus 1 minute intervals 
(p=0.169), consecutive visits (p=0.890) and consecutive measures (p=0.158). The effect of time 
interval on consecutive measures was evaluated for both groups, and no significant difference was 
noted (p = 0.99), a result supported by Tukey HSD post hoc testing (Figure 3 – 1). 
 Variable 
Control 
(mean ± SD) 
Dry eye 





I Osmolarity (mOsm/L) 287.9 ± 7.5 297.8 ± 14.7 0.007 
OSDI 7.1 ± 4.4 40.0 ± 14.8 <0.0001 







(TearLab™) 287.7 ± 8.01 295.8 ± 12.5 0.0058 
Osmolarity 
(Glass capillary tube) 282.4 ± 9.8 291.1 ± 9.9 0.041 
OSDI 7.09 ± 4.71 36.53 ± 11.89 < 0.001 
TBUT (sec) 20.82 ± 15.75 5.96 ± 2.68 < 0.001 





Figure 3-1. Mean osmolarity for each of the four measurements at 15 minute intervals and 1 
minute intervals. 
Because no difference was observed for osmolarity measures between the right and left eye, 
to simplify the statistical analysis the following results are described using osmolarity and TBUT 
measures from the right eye only. The mean coefficient of variation (CV) for osmolarity measures at 
15 minute and 1 minute intervals was 2.19/2.09% for controls and 3.48/3.31% for dry eye subjects. 
Pearson’s correlation coefficients were low for comparisons between a subject’s OSDI score and 
either TBUT or osmolarity, but by applying a bilinear fit,23 we were able to show a strong linear 
relationship between TBUT and osmolarity values (R = 0.85) [Figure 3 – 2]. ICC values were high 
for both 15 minute (ICC = 0.899) and 1 minute (ICC = 0.923) intervals, indicating good repeatability 
regardless of the time interval between measures. 









































Figure 3-2. Graphical representation of relationships observed between OSDI scores, 
osmolarity and TBUT. Only TBUT and osmolarity showed a high degree of correlation (R = 
0.85). 
Phase II included eight males and 22 females with a mean age of 36.7 ± 15.1 years, and a 
range between 20 and 73. Mean in vivo osmolarity in the control and dry eye group was 287.7 ± 8.01 
mOsm/L and 295.8 ± 12.5 mOsm/L respectively (p = 0.0058)[Table 3 – 1]. As observed in phase I, 
OSDI scores and TBUT were significantly different between the control group and the dry eye group 
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(p < 0.001 for both variables). No significant differences were observed between left and right eye 
osmolarity (p = 0.121) or TBUT measures (p = 0.724). Interestingly, a significant difference was 
noted between consecutive measurements (p < 0.001), however when measurements were factored by 
group, no significant difference between measurements was observed (p = 0.407) [Figure 3 – 3]. A 
post hoc Tukey HSD test did show that the difference between the first measurement and the last 
measurement in both the control group and dry eye group bordered on significance (0.05 < p < 0.054 
for both).  
 
Figure 3-3. Mean osmolarity of each measurement for the control and dry eye group. 
Relationships similar to those observed in phase I between osmolarity, TBUT and OSDI 
scores were also observed in phase II, although in phase II all were statistically significant, as 
indicated in Figure 3 – 4. Again, a bilinear function was fit to the data comparing TBUT and 
osmolarity, which demonstrated a significant linear relationship between the variables. The mean 
osmolarity of the tear film collected via capillary tube was 282.4 ± 9.8 mOsm/L in the control group 
and 291.1 ± 9.9 mOsm/L in the dry eye group (p = 0.041). Comparisons between measures taken in 
 Dry eye
























vivo versus those with the capillary tube were significantly different in the control group (p = 0.006), 
but were not significantly different in the dry eye group (p = 0.10). 
 
 
Figure 3-4. Relationships between OSDI, osmolarity, and TBUT in phase II. Only osmolarity 
and TBUT showed a high degree of correlation (R = 0.73), but all three were statistically 
significant. 
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 With the release of the results from the DEWS report, there has been a renewed interest in the 
use of osmolarity as a diagnostic marker of dry eye.13 The limiting factors in the adoption of 
osmolarity measures in a clinical or research setting has always been a lack of instrumentation that is 
compact and efficient, and the large volume of tears required by most osmometers for analysis. The 
introduction of the TearLab overcomes many of these methodological issues, but very little is known 
about its performance in normal and dry eye populations. 
There are only three independent reports that the author is aware of that present data gathered 
from the TearLab in normal and dry eye groups.24-26 Tomlinson et al. compared osmolarity measures 
using the TearLab to those obtained with the Clifton nano-osmometer in 36 subjects.26 Fifteen of the 
subjects were classified as dry eye based on non-invasive TBUT (NIBUT) of <10 seconds and being 
positive for symptoms of dry eye. They found TearLab mean osmolarity values of 308 ± 6.2 mOsm/L 
in the control group, and 321 ± 16.5 mOsm/L in the dry eye group, which correlated well with the 
results from the Clifton nano-osmometer (r = 0.904). A later study by Benelli aimed to use TearLab 
osmolarity measures as a method of charting the treatment efficacy of commercially-available 
lubricating eye drops in those suffering from symptoms of mild dry eye.24 60 participants were 
selected based on an OSDI score between 30 and 60, and a Schirmer test of <7mm after five minutes, 
then divided into three treatment groups. Mean osmolarity of each treatment group was 320.6 ± 2.0 
mOsm/L, 320.9 ± 3.4 mOsm/L, and 321.9 ± 2.7 mOsm/L. The largest, and most exhaustive, study 
published thus far evaluated tear osmolarity measures using the TearLab in 200 subjects, and failed to 
demonstrate a difference between the control and dry eye group, with a mean osmolarity of 307.1 ± 
11.3 mOsml/L and 308.9 ± 14.0 mOsm/L respectively.25 
The mean osmolarity of either the control or dry eye groups in the above studies are starkly 
contrasted to those in the present study. At approximately 288 mOsm/L, the osmolarity in the control 
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group for both phase I and II is almost 20 mOsm/L lower than those outlined above. Mean osmolarity 
in the dry eye group, 297.8 ± 14.7 mOsm/L, is again approximately 20 mOsm/L lower than two of the 
three studies outlined above. Readings in both groups that are consistently 20 mOsm/L lower than 
other published observations may suggest an issue with the instrument used in the study. However, 
the TearLab was calibrated daily per the manufacturer’s instructions with both an electronic chip card 
and saline calibration standards, and calibrated as expected each time. 
A possible explanation for the low observed osmolarity, particularly in the dry eye group, 
may be the use of a questionnaire to differentiate dry eye and control subjects. Although 
symptomatology plays an important role in the diagnosis of dry eye, numerous studies have shown 
that symptoms weakly correlate with objective signs of dry eye.19, 27-31 For example, Tuisku estimated 
correlations between OSDI and TBUT (r = -0.32), and OSDI and Schirmer’s (r = -0.47), the latter 
proving to be significant (p < 0.05).30 Conversely, another study was unable to show a significant 
relationship between Schirmer’s and OSDI (r = -0.182, p = 0.14), but was able to show a relationship 
between OSDI and TBUT (r = 0.296, p = 0.01).31 There is only one study that has specifically 
compared osmolarity measures to OSDI scores.19 Using the Advanced Instruments osmometer, very 
little correlation between the two variables was observed in a group of 40 mild-moderate dry eye 
sufferers (r = 0.033). Despite the presence of relationships between signs and symptoms of dry eye, 
the available data would suggest that the correlation is weak and quite variable. Certainly, 
comparisons made between osmolarity and OSDI scores in this study support that statement, as 
correlation coefficients were 0.37 for phase I and 0.47 for phase II. Therefore, it may have been 
prudent to include additional objective tests to better categorize our subjects. 
Multiple measurements are often used as a method for increasing accuracy and reducing the 
effects of the inherent variability of a given instrument. However, taking multiple samples, 
particularly in close succession, of the tear film may pose a problem as it may negatively influence its 
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natural state, and artificially inflate osmolarity readings. We were able to show that it is possible to 
safely collect four consecutive measurements, whether at 15 minute or 1 minute intervals, without 
significantly influencing osmolarity values in both dry eye and control subjects. It is notable that a 
gradual increase between successive measures was observed in the dry eye group using a one minute 
time interval (Figure 3 – 1), and it is likely that additional measures would cause a significant 
increase in osmolarity values. ICC values also indicated the instrument is highly repeatable when 
measures are taken at 15 minute or 1 minute intervals. Therefore, we recommend collecting no more 
than four samples from a given eye at 60-90 second intervals as a way to maximize accuracy and 
improve efficiency. 
The DEWS subcommittee report on the classification of dry eye listed two core mechanisms 
as the driving force behind dry eye – tear hyperosomolarity and instability.13 The hypothesis put 
forward was that in many cases of dry eye, tear film instability is the initiating event, and 
hyperosmolarity follows as a consequence. The strong relationship observed between TBUT, a 
commonly used method for estimating tear stability, and osmolarity in both phase I and phase II 
supports this theory. This also compliments earlier work by Liu et al. that provided indirect evidence 
of a link between hyperosmolarity and tear instability.32 A second measured variable in the study that 
supports the link between osmolarity and instability of the tear film was the observed coefficient of 
variation (CV) values in the dry eye group. The manufacturer states that the instrument has a CV of 
1.5%, a result that was independently confirmed elsewhere.24 Accounting for the expected CV of the 
instrument, the control group has a CV of approximately 0.65%, or ± 2mOsm/L and the dry eye 
group has a CV of 1.9%, or ± 6mOsm/L. This indicates that measured osmolarity values in a dry eye 
population will fluctuate around the mean a considerable amount, while measures in a normal 
population will remain relatively constant. Oscillations in osmolarity values is very suggestive of a 
 
 55 
tear film lacking stability, and therefore a better diagnostic criteria for dry eye may be an evaluation 
of an individual’s CV versus their mean osmolarity. 
Nelson and Wright evaluated potential sources of variation in tear osmolarity values in a 
small number of human subjects, with a focus on the effect of reflex tearing.20 They used light as a 
source of irritation to induce a reflex tearing response in six normal subjects, and subsequently 
observed a 5% drop in osmolarity values, from 302 mOsm/L to 289 mOsm/L. Current osmometry 
techniques require the collection of 5-10 µL of tears using glass capillary tubes, a process that can be 
time-consuming and difficult in those suffering severe dry eye.33 It is accepted, though has not been 
shown, that prolonged collection times and mechanical stimulation during collection will induce 
reflex tearing and lower osmolarity.18 Hence, it is reasonable to postulate that a degree of reflex 
tearing is occurring when a glass capillary tube is used to collect tears. Although we suspect that 
mechanical stimulation of the ocular surface is the driving force behind the reflex tearing response, it 
is possible that the response is a result of emotional tearing due to anxiety or fear related to the 
collection process. One might argue that the use of a glass capillary tube is a more intimidating 
collection method, and might therefore induce a degree of tearing independent of the collection. 
Another factor that should also be considered when interpreting the results of phase I is the 
assumption that the osmolarity of reflex tears is lower than that of basal tears. There have been 
conflicting reports about the osmolarity of tears that are hypersecreted. Gilbard artificially 
manipulated the flow rate of the rabbit lacrimal gland, and found that an increased flow rate, or 
hypersecretion, led to a decrease in fluid osmolarity.34 Other work with the rabbit lacrimal gland has 
shown the osmolarity to remain relatively constant despite flow rate.35 Unfortunately, there is not a 
study that has specifically looked at changes in human tear fluid osmolarity with changes in flow rate, 
a factor that warrants further investigation. 
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The second phase of the present study aimed to determine if differences existed in osmolarity 
values when samples are obtained from the glass capillary tube versus the TearLab. The TearLab is 
thought to avoid the pitfalls of capillary tube collection, as it requires minimal contact of the ocular 
surface and collection times are virtually instantaneous due to the low volume required. The results 
showed a 5 mOsm/L drop in osmolarity values in those samples collected using the glass capillary 
tube, which does imply that a reflex response does occur despite the use of a carefully controlled 
collection method. The decrease in osmolarity may in fact have been greater that what was observed, 
as it is possible that evaporation of the sample during multiple transfers could have raised the 
osmolarity slightly. Regardless, this difference between collection methods was statistically 
significant in the control group (p = 0.006), but was not statistically significant in the dry eye group (p 
= 0.10). 
Difficulty in the collection process using the glass capillary tubes, particularly in the dry eye 
group, limits the conclusions that can deduced from the results. Although collection efficiency with 
the glass capillary tube was high in the control group at 96.7% (464 out of 480 possible measures), it 
was only 71.9% (345 out of 480 possible measures) in the dry eye group. This limits the conclusions 
that can be gleaned from the statistical analysis, and if a more complete dataset existed for the dry eye 
group, it is likely that the observed difference between methods would have been significant. It is also 
probable that the majority of the missing data is from those who have the most severe dry eye, as they 
are usually the hardest to collect tears from, which further biases the results. Although this is a 
limitation, it is also supportive of the technical ability of the TearLab to obtain a sample in those with 
severe dry eye or small tear volumes. A second unknown is the effect that the glass capillary tube 
itself has on osmolarity. It is possible that the capillary tube interacts with the tear components 
contributing to osmolarity, and this is a factor that warrants further study. 
 
 57 
Overall, the present study has generated valuable data on the performance of the TearLab in a 
small subject population. It appears to be a repeatable method capable of collecting micro-volumes of 
tears from both normal and dry eye subjects, and in doing so, minimally perturbs the natural state of 
the tear film. In his extensive meta-analysis of literature relating to osmolarity, Tomlinson et al 
determined that using a cut-off osmolarity of 316 mOsm/L had a sensitivity of 59%, specificity of 
94% and positive predictive value of 89% for the diagnosis of dry eye.36 The observed mean 
osmolarity in the dry eye group for both phases of this study is so far below his suggested cut-off is of 
particular concern, and brings into question the ability of the TearLab to accurately identify those 
suffering from dry eye. This disparity may partially be explained by differences in instrumentation, as 
Tomlinson’s analysis was primarily based on results from freezing-point depression and vapour 
pressure osmometers. Nonetheless, it is apparent that additional studies are needed to generate data on 
the ability of the TearLab to discriminate those with dry eye from normals before its use will be 




in vitro analysis of the performance of the TearLab nano-
osmometer 
4.1 Introduction 
Although the previous chapter generated a significant amount of data on the performance of 
the TearLab in a research setting, it also raised a number of issues relating to the final results. 
Primarily, it was noted that the mean osmolarity in both the control (287.9 ± 7.5 mOsm/L) and dry 
eye (297.8 ± 14.7 mOsm/L) group was significantly lower than other studies using the same 
instrument have reported.1-3 One of the major contributors to the result may have been the use of a 
subject’s Ocular Surface Disease Index (OSDI) score as a grouping criteria. However, there may also 
have been instrument-specific factors that played a role. One of the most obvious variables with the 
TearLab is the effect of different chip cards on an individual measure, particularly since a new chip 
card is used for each measurement. All chip cards from a given lot have two unique identifiers, one 
being a batch history record (BHR), and the second being a code (Figure 4 – 1A). The code identified 
on the chip card (Figure 4 – 1B) must be entered into the instrument before a measure is made as a 
way of compensating for the known variability of the lot. It is currently unknown if using different 
chip card lots will have any influence on osmolarity readings. Therefore, one purpose of this study 




   
 
Figure 4-1. (A) TearLab chip card package displaying the lot, batch history record (BHR), and 
code. (B) Chip card on the collection pen with the code presented. 
Data from the previous chapter also demonstrated a lower osmolarity when tears were 
collected in vivo using the glass capillary tube (GCT), which was hypothesized to be due to induction 
of reflex tearing. However, the difference observed in osmolarity may be secondary to issues with the 
GCT method itself, such as a reduced uptake, or evacuation, of factors contributing to tear osmolarity 
(electrolytes and proteins). This concept is supported in a previous study by Jones et al., in which two 
different methods for the collection of tear film were evaluated, and their relative efficacy of protein 
recovery compared.4 The first method involved a GCT, and the second method used a porous 
polyester rod. They showed that although there was not a statistically significant difference in protein 
recovery, there was a trend towards reduced efficiency using the GCT. This would suggest that either 
the GCT has reduced uptake of the proteins, or the proteins are interacting within the GCT, 
preventing their evacuation out of the tube. Although proteins do not significantly contribute to 
osmolarity of the tear film, the electrolytes may interact similarly with the GCT. The second portion 





The first portion of this study aimed to determine the effect of chip card lot/code on the 
measured osmolarity. To do so, two different control solutions of known osmolarity were used in 
combination with three different chip card batches (Code 3, 5 and 10). The associated lot and batch 
history record (BHR) for each chip card batch is shown in table 4 – 1. 
Code Lot BHR 
3 14 08-0354 
5 17 433 
10 29 675 
Table 4-1. Description of lot and batch history record (BHR) for the three chip cards used 
throughout the experiment. 
The two solutions used were the standard calibration controls for the TearLab, consisting of a 
normal and a high control. The normal control has an expected osmolarity of 292 ± 12 mOsm/L and 
the high control is expected to measure 338 ± 15 mOsm/L. Six chip cards were used from each batch 
to measure the same control, for a total of 18 measures on the normal control and 18 measures on the 
high control. The order in which each chip card was used was randomized.  
The second portion of the experiment utilized three different control solutions to evaluate the 
effect of collection method on tear osmolarity.  Two of the solutions were the control solutions 
provided by TearLab for daily calibration of the instrument outlined above, and the other was a 
contrived artificial tear solution (ATS) of known osmolarity. The ATS (Bionostics, Inc. Devens, MA, 
USA) was comprised of a complex mixture of ions, proteins, lipids and metabolites that mimicked the 
human tear matrix and had a known osmolarity of 294 mOsm/L. Sample size was determined using 
the observed mean and standard deviation obtained from the in vivo portion of Chapter 3 and setting 
the statistical power to 0.50. This resulted in a sample size of 18, meaning that for each control 
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solution, 18 measures would be taken using the TearLab, and 18 taken using the glass capillary tube. 
For each control, three different vials were used, with each vial being from the same lot, to eliminate 
lot-to-lot variation. Additionally, to minimize evaporative effects, vials were opened and sequentially 
measured 6 times with each method before being discarded. 
The technique used for both portions of the experiment to measure osmolarity with the 
TearLab was relatively quick and simple. For each new chip card, the collection tip was carefully 
inserted into the vial opening to collect the sample, and then returned to the docking station for 
completion of the measure. The general technique used to obtain and process a sample of solution 
using the GCT was outlined previously (Chapter 3), but was slightly modified to fit within the 
constraints of the current experiment. In this case, the GCT was inserted into the control vial, 
whereupon 5µL of solution was collected. The contents of the GCT were immediately transferred to a 
0.1mL PCR tube (Axygen Scientific Inc., Union City, CA, USA) and spun down for 7 seconds at 
approximately 6500rpms, then placed on ice. 500nL of the sample was aliquoted onto a clean 1” 
square of Parafilm (Pechiney Plastic Packaging Company, Chicago, IL, USA) and immediately 
collected by placing the collection tip of the TearLab into the dispensed sample. 
4.3 Statistical analysis 
All gathered data was transferred to a Microsoft Excel spreadsheet (Microsoft Corp., 
Redmond, WA, USA) and imported to Statistica version 7 (Statsoft, Tulsa, OK, USA) for analysis. A 
one-way ANOVA was used to evaluate differences between batches, followed by post hoc analysis to 
further elucidate where any differences lay. A t-test for independent samples was used to compare 
osmolarity of samples collected directly with the TearLab or with the GCT. A repeated-measures 
ANOVA was also used to evaluate the impact of various factors, including control osmolarity and the 





The ANOVA of batch effects of the chips resulted in significant differences whether the 292 
mOsm/L control (p < 0.001 or the 338 mOsm/L control (p < 0.001 was used (Figure 4 – 2A and 4 – 
2B respectively). Tukey HSD determined that regardless of control osmolarity, batch 10 was 
significantly different than batch 3 or 5 (p < 0.002), while the mean osmolarity of those batches were 
statistically similar (p > 0.78). 
 
Figure 4-2. The results of the analysis of batch effects on mean osmolarity of the 292 mOsm/L 
control solution (A) and 338 mOsm/L solution (B), p < 0.001 in both cases. 
Mean osmolarity of those samples taken directly from the vial was 295.8 ± 19.22 mOsm/L, 
and 300.3 ± 18.9 mOsm/L for those that were first collected via capillary tube, a difference which 
was not statistically significant (p = 0.23). Statistically significant differences were observed between 
the mean osmolarity of the three controls (p < 0.001), and this difference was still present when one 
factored in whether the control was measured with the TearLab or with the capillary tube (p = 0.003). 
However, post hoc analysis revealed that no differences were present between measurement methods 


















































Figure 4-3. Comparison of mean osmolarity for the three controls sampled either directly by 
the TearLab or by the glass capillary tube. 
When comparing the three vials used in each control group, differences were again noted 
amongst the ATS group, with all three vials measuring significantly different from one another 




























Figure 4-4. Mean osmolarity of each of the three vials used as a control. 
4.5 Discussion 
Although this was a relatively simple in vitro experiment, it has yielded unique insight into 
the functioning of the TearLab. The first portion of the experiment demonstrated that different chip 
card codes/lots can have a significant influence on measured osmolarity. For the 292/338 mOsm/L 
controls, Code 10 chip cards had a mean osmolarity of 300.7/334.2 mOsm/L, significantly higher 
than both code 3 (280.7/310.7 mOsm/L) and 5 (277.2/309.8 mOsm/L) chip cards. It is particularly 
worrisome that a 20 mOsm/L difference between individual lots existed, as a 20 mOsm/L difference 
can easily lead to either an over- or under-diagnosis of dry eye. Also of concern is the difference 
between the observed and expected osmolarity of the calibration controls. TearLab expects a 
deviation of ±12 mOsm/L in the case of the 292 control, and ±15 mOsm/L in the case of the 338 
control. For the 292 control, only lot 3 and 10 would have fallen within the expected range and for the 
338 control, only lot 10 was within the expected range. 
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 Vial 2






















The second portion of the experiment showed that although a statistically significant 
difference between collecting directly with the TearLab or with the GCT did not exist, the GCT 
appeared to nonetheless measurably influence osmolarity. In contrast to the previous in vivo study, 
which observed a 5 mOsm/L decrease in osmolarity, the present study demonstrated a 5 mOsm/L 
increase in osmolarity. This increase is likely attributable to evaporative effects, as the fluid was 
transferred multiple times before being measured on the TearLab. A surprising result was the 
significant difference in ATS osmolarity as measured with the GCT versus the TearLab. The primary 
purpose of the lipid layer in the human tear film is to form a barrier between the aqueous portion and 
the surrounding environment, thereby minimizing evaporation and maintaining osmolarity.5 
Therefore, one would expect that the lipids present in the ATS would perform the same function, and 
negate any evaporative effects that would occur during fluid transfer. This did not appear to be the 
case, as the osmolarity was significantly higher when measured with the GCT. 
One possible explanation for the increased osmolarity may have been the collection technique 
used to gather the sample using the GCT. In the ATS, the hydrophobic nature of lipids would likely 
keep them on the surface of the solution. When the ATS was collected from its storage vial, the GCT 
was placed down into the solution, and it is possible that because collection was taking place well 
below the surface, very few lipids were collected. Without the lipid layer present, the aqueous portion 
was able to evaporate and concurrently increase osmolarity of the ATS. 
As noted earlier, both control solutions have a fairly large range of expected osmolarity and it 
is possible that this range is secondary to variations in the manufacturing process of the controls. 
Figure 4 – 4 clearly shows no significant difference observed between the three vials used for the 292 
and 338 mOsm/L controls, which suggests that the range may in fact be due to variations in the chip 
cards. Differences were present between the three contrived ATS, but this is perhaps less surprising 
given the complexity of the solutions. 
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The primary limitation of the present study was the low sample size, particularly for the 
portion that evaluated batch effects. This is a reflection of the significant cost involved for each chip 
card, estimated to be $15-25 per card. A small sample size lowered the statistical power, but the effect 
size appears to be significant enough to stand as being a true observation. A second limitation is the 
unknown effect of time on the viability of the chip cards. The oldest chip cards, batches 3 and 5, were 
received approximately 10 months before the present study was carried out, while the newest of the 
chip cards, batch 10, was received only 5 months prior. Coincidentally, it was batch 3 and 5 that were 
significantly different from batch 10; however, they were not different from one another. Chip cards 
were used well in advance of their stated expiry date, and all were stored in temperature and humidity 
controlled environments with no exposure to sunlight or electrical devices that could interfere with 
their functioning. This raises the possibility that there is a temporal degradation in the chip card’s 
measurement abilities, and warrants further investigation. 
In conclusion, there appears to be some technical issues with the operation of the TearLab, 
the majority of which are related to the chip cards. As the instrument is relatively new and the large-
scale manufacturing process of the chip cards is in its infancy, it is hoped that many of these concerns 




Evaluation of the relationship between tear film osmolarity, tear 
meniscus height and symptoms of dry eye 
5.1 Introduction 
 Tear osmolarity has been cited as the ‘gold standard’ for the objective diagnosis of dry eye,1 
and has been attributed to many of the signs and symptoms observed throughout the natural history of 
the disease process.2, 3 Gilbard, an early pioneer in tear osmolarity research, postulated in 1986 that 
hyperosmolarity was a function of either increased evaporation rates of the tear film from the ocular 
surface, or decreased production of the aqueous layer by the lacrimal gland.4 He also suggested a 
third possibility, based on work undertaken with rabbit lacrimal gland ducts,5 which is that the 
osmolarity of lacrimal gland fluid itself increases, although no human study has supported this 
concept. His postulates have persisted, and the Dry Eye Workshop document pertaining to the 
definition of dry eye stated “The major causes of tear hyperosmolarity are reduced aqueous tear flow, 
resulting from lacrimal failure, and/or increased evaporation from the tear film.”6 A distinct 
implication of the DEWS document and Gilbard’s work is that tear film osmolarity may be volume-
dependent. 
 Tear meniscus height (TMH) has been proposed as a clinically useful estimate of the volume 
of the tear film.7 If measured without the use of fluorescein as an indicator it is non-invasive, and it 
has relatively high sensitivity and specificity for the diagnosis of dry eye.8 For the aforementioned 
reasons, Fourier-domain optical coherence tomography (FD-OCT) is ideally suited to measure TMH, 




 The primary objective of this study was to determine if a relationship exists between 
osmolarity and TMH measures in a mild-moderate dry eye population. A secondary objective was 
whether various subjective ratings of dry eye symptoms corresponded to either osmolarity or 
meniscus height. 
5.2 Methods 
 The study was cleared by the Office of Research Ethics at the University of Waterloo and 
adhered to all tenets of the Declaration of Helsinki. Forty-five subjects were recruited for 
participation in the study and the primary inclusion criterion was a score of ≥ 20 on the Ocular 
Surface Disease Index (OSDI). Subjects were excluded from participation if they had undergone 
refractive surgery or if conjunctivochalasis was present. Subjects were asked to refrain from contact 
lens wear 24 hours before their visit and to avoid the use of artificial tear solutions for six hours prior 
to their visit. After receiving a subject’s informed consent, a five-question linear visual analogue scale 
(VAS) designed to subjectively rate common symptoms of dry eye was completed. The five 
symptoms evaluated were comfort, dryness, burning, grittiness and clarity of their vision, and a rating 
was given for each eye on a interval scale of 0 – 100 (0 being severely symptomatic and 100 
representing no symptoms). 
 Tear meniscus height measurements were then obtained on each eye in triplicate using the 
RTVue-100 Fourier-domain optical coherence tomographer (Optovue, Freemont, CA, USA). The 
CAM-S (Cornea/Anterior Module – Short) lens was used for all measurements, using the default 
settings of the instrument. The measurement was taken at the six o’clock position of the cornea, and 
the 2.0mm scan beam was aligned so that its midway point bisected the margin of the lower lid. 
Subjects were asked to maintain their habitual blink frequency, and images were captured 
immediately after a blink. Image analysis was conducted using the integrated software, and the 
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meniscus height was defined as the vertical difference between the point at which the tail of the 
meniscus intersected with the cornea superiorly and the lower lid inferiorly. 
 At the conclusion of the study visit, four tear samples were taken from each eye of the subject 
using the TearLab nano-osmometer (TearLab Corp., San Diego, CA, USA). To collect the tears, 
subjects were instructed to direct their gaze superonasally, whereupon the tip of the chip card was 
gently placed into the tear meniscus near the lateral canthus. Care was taken to minimize contact with 
the ocular surface and avoid a reflex tearing response. After a successful collection, the pen and chip 
card were immediately returned to the docking station for analysis. 
5.3 Statistical analysis 
 All data was entered into Excel spreadsheets (Microsoft Corp., Redmond, WA, USA) and 
subsequently exported to Statistica version 7 (Statsoft, Tulsa, OK, USA) for analysis. Relationships 
between age, TMH, OSDI and osmolarity values were evaluated using Pearson’s correlation co-
efficient, with p > 0.60 considered a high strength of agreement. A repeated measures ANOVA was 
used to evaluate any differences in TMH, osmolarity and linear VAS values for the right and left eye. 
Subjects were then stratified into four groups based on their mean osmolarity and TMH values of the 





Low/Low < 300 < 0.3 
Low/High < 300 > 0.3 
High/Low > 300 < 0.3 
High/High > 300 > 0.3 
 
Table 5-1. Breakdown of grouping criteria based on tear osmolarity and tear meniscus height. 
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 The cut-off value of 300 mOsm/L was selected for osmolarity based on the approximate 
mean osmolarity of the dry eye group observed in Chapter 3. The TMH cut-off of 0.3mm was based 
on the work of Ibrahim et al., who determined that a TMH value of 0.3mm had a sensitivity and 
specificity of 67% and 81% respectively for the diagnosis of dry eye.9 One-way ANOVAs were used 
to evaluate differences in objective and subjective data between the four groups, and a post hoc Tukey 
HSD test was used as appropriate to determine where, if any, differences existed. A p-value of < 0.05 
was considered statistically significant. 
5.4 Results 
 Nine of the subjects were male, and 36 were female, and the mean age of all subjects was 47 
(range 17 – 79). Mean TMH for the right eye was 0.281 ± 0.123mm and for the left eye was 0.297 ± 
0.130mm, a difference that was not statistically significant (p = 0.34). Osmolarity values for the right 
and left eye, 302.9 ± 16.4 mOsm/L and 301.2 ± 14.8 mOsm/L respectively, were also not 
significantly different (p = 0.21). Pearson’s correlation coefficient did not describe a significant 
relationship between TMH and osmolarity (r = -0.14, p = 0.36)[Figure 5 – 1]. No difference was 
observed between left and right eyes for linear VAS values (p = 0.94). Pearson’s correlation 
coefficients were unable to demonstrate relationships between age, OSDI scores, osmolarity or TMH 
measures, although the relationship between OSDI score and osmolarity bordered on statistical 




Figure 5-1. Plot of osmolarity versus TMH with the line of best fit showing a trend of decreased 
TMH as tear osmolarity increases. 
 No difference was observed between each of the five symptoms rated as part of the linear 
VAS (p = 0.99), nor were any of the symptoms statistically different from one another when the 
grouping criterion was taken into consideration (p > 0.60). Taking the mean value of all symptoms 
rated, those in the Low/Low group had the lowest mean value, with an average rating of 54.5. Those 
in the High/High group had the highest average rating, at 61.3. A significant difference was noted in 
age between groups, particularly between the Low/Low group and the High/Low group (p = 
0.036)[Figure 5 – 2]. As expected, the TMH and osmolarity was also significantly different between 
groups (p < 0.000). 
 





















Figure 5-2. Mean age and 95% CI of subjects in each group. 
5.5 Discussion 
 There are a number of studies that have evaluated tear meniscus height and tear dynamics in a 
dry eye population using either a custom-built OCT8, 10, 11 or a commercially available anterior-
segment OCT (AS-OCT).9, 12 Using a custom-built real-time OCT, Shen et al. found a mean TMH of 
0.196 ± 0.023mm in the right eye and 0.190 ± 0.024mm in the left eye in a group of 48 subjects with 
aqueous-deficient dry eye (ADDE).8 Yuan et al. used the same instrument setup and similar grouping 
criteria to measure the lower TMH before, during and after the interblink period, and observed a 
mean TMH of 0.237 ± 0.100mm immediately following a blink. In close agreement with Yuan et al.’s 
measure of lower TMH, Ibrahim et al. used a commercially-available Visante AS-OCT to image the 
upper and lower TMH of 24 dry eye subjects, and found a mean TMH of 0.25 ± 0.08mm.9 
 The high mean (0.290mm) and standard deviation (0.126mm) of the TMH observed in this 
study versus other studies is likely due to two factors: grouping criteria and instrument differences. 























Chen et al.,10 Shen et al.,8 and Yuan et al.11 all used subjects suffering from ADDE, a group that one 
would expect to have very low tear volumes and hence, low TMH. By using the OSDI as our 
grouping criteria we were much less specific, and therefore have included those with ADDE and 
those with evaporative dry eye (EDE). It has been suggested that EDE disease is characterized by a 
normal-high tear volume as a result of a compensatory lacrimal reflex response to the compromised 
meibomian glands.13 This will subsequently lead to a higher meniscus height, and may account for the 
higher mean and standard deviation observed. Geographical and racial differences may also influence 
results, made apparent by the Shen et al.(carried out in Miami, FL, USA) and Yuan  et al.(carried out 
in Wenzhou, Zhejiang, China) studies that used the same grouping criteria and instrument, but had 
very different results.8, 11 Instrument specific differences have been demonstrated in comparative 
studies between various types of commercially-available OCTs.14, 15 Variations in instrument-specific 
algorithms for determining image parameters have been suggested as the cause of such differences, in 
addition to the differences in resolution of the various instruments. Unfortunately, there is no 
published study that the author is aware of that has evaluated the TMH measurements in a dry eye 
population using the RTVue-100. Therefore, some caution must be taken when comparing the results 
of our study to those outlined above. 
Tear osmolarity values observed in the present study, at 302.9 ± 16.4 mOsm/L for the right 
eye and 301.2 ± 14.8 mOsm/L for the left eye, remain well-below what one might expect based on the 
recruitment of mild-moderate dry eye sufferers. Other studies that have used the TearLab have found 
mean osmolarity values in the dry eye group in the range of 309 – 321 mOsm/L.16-18 As noted and 
expanded upon in Chapter 3, the lower than expected values might suggest that there is an issue with 
our instrument or the method we used to select our study population. If the TearLab used in the study 
is not functioning in the same manner as other devices it may explain the lack of an association 
between TMH and osmolarity. However, one other study that looked to correlate TMH and 
 
 74 
osmolarity in those with nasolacrimal duct obstruction failed to show any association between the two 
variables.19 
The concept of associating specific symptoms with various ocular surface abnormalities is 
certainly not new. Varikooty used psychophysical methods to demonstrate various mechanical 
(scratchy, dry), chemical (burning, stinging) and itch symptoms throughout the interblink period.20 He 
was able to show that immediately after a blink, mechanical (38%), chemical (33%) and itch (29%) 
symptoms were all experienced with approximately equal frequency. However, near the end of the 
interblink period, symptomatology had shifted and 91% of symptoms were chemical, 9% mechanical 
and no itch was perceived. A more recent study by Liu et al. used visual analogue scales (VAS) to 
rate the overall intensity of discomfort of hyperosmolar solutions between 300 and 1000 mOsm/kg 
that were instilled in the eye.21 One drop of either a sodium chloride or sucrose solution was placed 
into one eye, followed immediately by each subject rating burning, stinging, irritation, pricking and 
cooling on the VAS. They were able to show that as the osmolarity of the instilled solution increased, 
the intensity of symptoms similarly increased in a linear fashion. A statistically significant difference 
was demonstrated between symptoms, as irritation, burning and stinging were reported at high levels, 
and cooling was reported the least. 
 In the present study, dryness and grittiness had the lowest values, indicating they were 
perceived to be the most intense of the symptoms, although they were not significantly different than 
the other symptoms evaluated. We also failed to demonstrate a symptom that appeared to be more 
prevalent within a single group. One reason may be an inherent issue of using VAS, namely the non-
linearity of such scales. In a comparison of the consistency between a VAS and a discrete scale 
designed to measure the same variable, subjects were asked to rate pain on the VAS and a 7-point 
scale with descriptive wording tied to each value (0 being no pain, 6 being unbearable pain).22 A high 
degree of variability and overlap was found between VAS scores and each category of the discrete 
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scale, which suggests that scores are individual and should not be used for group descriptions. A 
second reason may have been a lack of training of subjects to accurately quantify their symptoms. In 
the study by Liu et al. outlined above, all subjects had previous psychophysical training to detect 
small differences in corneal sensation before they participated.21 Training of subjects may have 
eliminated some of the known variability of the VAS and improved the responses. 
 Bron et al. have recently published some work on the pathophysiology and hypothesized key 
mechanisms behind dry eye.13 This paper summarized current literature to characterize ADDE and 
EDE, and also described a late-stage hybrid form, wherein ADDE would take on some of the 
characteristics of EDE and vice versa.13 The breakdown of mean age by group, as seen in Figure 2, 
may yield some insight into the temporal development of dry eye and support some of the 
suppositions put forward by Bron.13 It is possible that the Low/Low group, which had the lowest 
mean age at 31, represents an early-ADDE group, as they have a low meniscus, but not the high 
osmolarity that Bron believed would be present. A low osmolarity could be maintained within this 
group due to a stable lipid layer, and various papers have established the increased lipid stability and 
volume and decreased evaporation that occurs in younger people.23-25 Interestingly, the Low/Low 
group was also the most symptomatic, although only slightly so, a finding which may be due to the 
increased corneal sensitivity noted in those who are younger.26 The Low/High and High/High group 
likely represents those with EDE disease based on mean age of the two groups (approximately 45 
years) and the high meniscus. The increased age makes this group more likely to undergo changes to 
the meibomian glands that result in decreased tear stability and increased evaporation.23-25 The higher 
meniscus is secondary to an increased sensory drive from the ocular surface in response to local 
alterations of osmolarity that results in an increased lacrimal response. Finally, I propose that the final 
group, High/Low, represents the hybrid form suggested by Bron et al., and is the end-stage of the 
disease.13 For those in the High/Low group who began with EDE, a chronic dry eye state has induced 
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corneal hyposensitivity,27, 28 and reduced the sensory drive to generate a compensatory reflex 
response. This results in a tear film exhibiting a high osmolarity and low tear volume. For those in the 
High/Low group who began with ADDE, the natural decline of meibomian gland secretions has 
marginally reduced tear stability, but coupled with the already present loss of lacrimal flow, results in 
a low volume, high osmolarity state. 
Although the present experiment could not determine the existence of a relationship between 
osmolarity and TMH, or identify predominant symptoms within distinct dry eye groups, it has made 
some interesting observations regarding the possible temporal development of dry eye disease and its 
sub-types. It is important to note that this study was not designed to test a hypothesis regarding the 
temporal evolution of dry eye disease, and future work is needed to elucidate whether these 





 The aim of this thesis was to use two new commercially-available devices, the RTVue-100 
Spectral/Fourier-domain optical coherence tomographer (SOCT) and the TearLab nano-osmometer, 
to generate data on commonly used objective parameters for the diagnosis of dry eye.  
 The experimental portion of Chapter 2 measured tear meniscus height (TMH) in 50 subjects 
and demonstrated the significant differences that existed between a time-domain optical coherence 
tomographer (TOCT) and SOCT when measuring TMH. One factor attributed to the observed 
difference was the dewarping algorithm that the SOCT employs for proper imaging of the anterior 
segment, a feature that the TOCT does not use. The SOCT also had a larger measured TMH than the 
TOCT, and may be a result of the increased resolution of SOCT, which made delineation of the 
(particularly the upper meniscus) meniscus much easier. Despite the observed differences, the 
SOCT’s standardized integrated analysis software made TMH measurements easier and allows for 
consistency between multiple centres that are using TMH as a variable, and we therefore advocate its 
use. 
 Chapter 3 was a two-phase study that presented preliminary data on the functionality of the 
TearLab nano-osmometer. The primary objective of the study was to generate data using the TearLab 
in both a normal and dry eye population. Mean osmolarity for normals was approximately 288 
mOsm/L and for the dry eye group was approximately 297 mOsm/L and although these two groups 
proved to be significantly different from one another, the results are substantially lower than other 
published studies, including those using the TearLab.1-7 The results do bring into question the 
accuracy of the instrument, and provided the impetus for the study performed in Chapter 4. 
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One of the major barriers to the acceptance of tear osmolarity as a clinical test has been the 
difficulty of collecting a tear sample while minimally disturbing the tear film. With this in mind, a 
second objective of the study in Chapter 3 was to determine whether any difference in osmolarity 
values would be observed whether tear collection was performed using a glass capillary tube or the 
TearLab. The glass capillary tube measures were 5 mOsm/L lower than those collected by the 
TearLab, a difference that was statistically significant. This suggests that despite careful collection 
practices, the glass capillary tube induces a degree of reflex tearing, which artificially lowers 
osmolarity. A significant difference in osmolarity between collection techniques was not 
demonstrated in the dry eye group, owing to difficulty in successfully collecting tears using the glass 
capillary tube. The ability of the TearLab to collect tears in those with moderate dry eye, and possibly 
a low tear volume, highlights one of the major technical advantages of the TearLab over other 
collection techniques. The final objective of Chapter 3 was to evaluate whether a short (1 minute) or 
long (15 minute) interval between multiple collections would yield a reproducible result. The results 
showed high repeatability (ICC values greater than 0.89) and minor influence on tear osmolarity 
values whether collections were performed at 1 or 15 minute intervals. To maximize efficiency, we 
concluded that a maximum of four tear collections could take place spaced 60-90 seconds apart 
without negatively influencing tear osmolarity. Perhaps the most interesting finding of the third 
chapter was the strong relationship between tear break-up time (TBUT), an established measure of 
tear stability, and tear osmolarity. Tear stability and osmolarity are inextricably linked in the current 
literature as core mechanisms in dry eye development, despite very little objective evidence 
associating the two; however, this experimental discovery supports and adds justification to that 
connection. 
Chapter 4 used in vitro methods to elaborate on findings from Chapter 3, particularly the low 
osmolarity observed in both groups. As each measure is performed using a new chip card, an obvious 
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source of error may have been differences between chip cards. The results of Chapter 4 supported that 
hypothesis, as significant differences were noted between three different batches of chip cards that 
were used throughout the study conducted in Chapter 3. A second purpose of Chapter 4 was to 
determine if the glass capillary tube collection method was responsible for the decrease in osmolarity 
detected in Chapter 3. Calibration standards and a contrived artificial tear were employed to establish 
that using a glass capillary tube does not alter solution osmolarity, validating the results of Chapter 3. 
Chapter 5 brought together aspects of previous chapters to answer two experimental 
questions: is osmolarity merely a function of tear volume, and are there any predominant symptoms 
in those with tear dysfunction? 45 subjects with mild-moderate dry eye had TMH, osmolarity and 
linear visual analogue scales measured. No significant relationship could be observed between any of 
the variables. The subjects were also placed into sub-groups for further analysis based on their TMH 
and osmolarity results. The most intriguing finding of the secondary analysis was the mean age of 
each sub-group, which fit nicely into the model proposed by Bron for the development of aqueous-
deficient dry eye (ADDE) and evaporative dry eye (EDE).8 
Chapter 2 and 4 also focused on the correlation of osmolarity with various objective and 
subjective measures of dry eye. Chapter 2 managed to establish a strong relationship between 
osmolarity measures and tear-break up time, and also provided some evidence of a weak, but 
statistically significant, relationship between osmolarity and OSDI scores. Chapter 4 was unable to 
demonstrate a significant relationship between specific dry eye symptoms and osmolarity or TMH. 
The inability to correlate signs and symptoms of dry eye is not new,9, 10 but it does serve to remind 
that the absence of a relationship does not imply the absence of dry eye. As suggested elsewhere11 and 
supported within this thesis, multiple diagnostic tests are needed for the accurate diagnosis of dry eye. 
Although this thesis primarily related to techniques for the objective analysis of the tear film, 
it also served to evaluate the role of technology in research and clinical practice. An exponential 
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increase in the fundamental understanding of the function/structure of the human eye has driven the 
development of a wealth of instrumentation for its measurement and analysis. With the introduction 
of any new device, it is important that three aspects of the instrument are established: utility, 
accuracy, and precision. From a clinical perspective, an instrument has utility if it can assist in the 
management of a given condition, and determine whether or not treatment needs to be initiated. 
Accuracy is determined through the calibration of the instrument and comparison to accepted 
standards, and certainly the importance of calibration was established in Chapter 2. Finally, the use of 
multiple measures is employed to determine instrument precision, and this was a particular topic of 
interest throughout Chapter 3 and 4 in relation to the TearLab. 
As an instrument for the analysis of tear meniscus height, the RTVue-100 performed 
admirably. The high-resolution images it produces make for easy determination of the meniscus 
borders, and the user-friendly integrated software allows for analysis of captured images. 
Additionally, it is capable of obtaining images quickly, and non-invasively, which reduces any effect 
it may have on the tear film. The interchangeable lenses (CAM-S and CAM-L) allow the RTVue-100 
to image anterior-segment structures at different resolutions, giving the instrument greater flexibility. 
Despite the two lenses allowing for different scan lengths to be used, the biggest downside of this 
instrument is the maximum scan length of 6mm, meaning that only the upper or lower meniscus can 
be imaged at a given time. An improvement would be the ability to image a larger area of the ocular 
surface, closer to the 16mm scan length of the Visante device. Regardless, the implementation of the 
RTVue-100 in clinical or research practice is advocated. 
Despite the reported importance as a single objective test with high sensitivity,7 osmolarity 
measures have failed to be introduced into clinical practice due to a lack of instrumentation that is 
compact, user-friendly, cost-efficient and minimally-invasive. The TearLab appears to have overcome 
several of these limitations and throughout the various studies proved itself to be incredibly adept at 
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the collection and efficient analysis of tear osmolarity. Its novel use of lab-on-a-chip technology for 
the measurement of osmolarity is a significant step forward and positions the device for acceptance as 
a diagnostic tool. However, some technical issues remain and chief among those was the variance of 
measures due to different chip cards that was demonstrated as part of Chapter 4. A second issue with 
the device was the wide range of values considered acceptable for calibration purposes. Normal 
calibration solutions are expected to measure 292 ± 12 mOsm/L and high calibration solutions are 
expected to measure 338 ± 15 mOsm/L. When one considers the minute difference between a normal 
osmolarity (302 mOsm/L) and dry eye osmolarity (316 mOsm/L),7 the TearLab may not have the 
sensitivity required to differentiate the two. These factors, in addition to the range of TearLab 
osmolarity values reported in the literature,1, 2, 12 clearly demonstrates that further work is required to 
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